Ophthalmology – Lacrimal Gland Tumors

Basics

Description

Lacrimal gland tumors and masses comprise a broad group of disorders involving the lacrimal gland in the superotemporal orbit. They may be:

• Epithelial or nonepithelial
• Benign or malignant
• Inflammatory or neoplastic
• Primary or metastatic

Only a minority of orbital lesions arise from the lacrimal gland, and most lacrimal gland enlargements are nonepithelial, particularly inflammatory or lymphoid disorders.

Important categories include:

• Inflammatory dacryoadenitis
• Idiopathic orbital inflammatory disease
• Sarcoidosis
• Lymphoid tumors
• Dacryops
• Pleomorphic adenoma
• Adenoid cystic carcinoma
• Other epithelial malignancies
• Metastatic disease

The clinical behavior varies widely, so the tempo of growth, presence of pain, globe displacement, imaging characteristics, and bone involvement are particularly important.

Epidemiology

Approximately 10% of orbital lesions involve the lacrimal gland.

Most lacrimal gland lesions are nonepithelial. Important nonepithelial causes include:

• Inflammatory disease
• Lymphoma
• Reactive lymphoid hyperplasia
• Sarcoidosis

Among epithelial tumors, benign lesions include pleomorphic adenoma and ductal cysts such as dacryops, while adenoid cystic carcinoma is one of the most important malignant epithelial tumors.

Adenoid Cystic Carcinoma

Adenoid cystic carcinoma can occur at almost any age but most often presents in adulthood.

It is notable for:

• Relatively rapid progression
• Pain
• Bone destruction
• Perineural invasion
• Local recurrence
• Potential intracranial and systemic spread

Pain is an especially important warning sign because perineural invasion is characteristic.

Dacryops

A dacryops is a ductal cyst involving the lacrimal gland, often the palpebral lobe.

It is usually:

• Benign
• Slowly growing
• Painless
• Occasionally visible beneath the superior temporal conjunctiva

Many require no treatment unless they become symptomatic or enlarge.

Lymphoid Lesions

Lymphoid disease of the lacrimal gland includes:

• Reactive lymphoid hyperplasia
• Atypical lymphoid hyperplasia
• Non-Hodgkin lymphoma

Orbital lymphoma is more common in older adults and often presents as a painless, slowly enlarging lacrimal gland mass.

Idiopathic Orbital Inflammation

Idiopathic orbital inflammatory disease may involve the lacrimal gland and present as inflammatory dacryoadenitis.

It commonly produces:

• Acute pain
• Swelling of the lateral upper eyelid
• Tenderness
• Conjunctival injection
• Diplopia
• Proptosis

A rapid response to corticosteroids may occur, but corticosteroid responsiveness does not by itself establish the diagnosis.

Sarcoidosis

The lacrimal gland is one of the most commonly affected orbital structures in sarcoidosis.

Lacrimal gland involvement may be:

• Bilateral
• Painless or mildly uncomfortable
• Associated with dry eye
• Associated with systemic pulmonary, skin, or lymph node disease

Sarcoidosis is particularly important in younger and middle-aged adults.

Risk Factors

Risk factors depend on the underlying pathology.

Malignant Epithelial Tumors

Important concerns include:

• Previous incomplete excision of a lacrimal gland epithelial tumor
• Recurrent pleomorphic adenoma
• Longstanding lesion with recent acceleration in growth

Incomplete excision of pleomorphic adenoma can lead to recurrence and, rarely, malignant transformation.

Lymphoma

Sjögren syndrome and other chronic autoimmune conditions may increase the risk of ocular adnexal lymphoma.

Inflammatory Disease

Immune-mediated disease and systemic inflammatory disorders may predispose to lacrimal gland inflammation.

Genetics

Genetic abnormalities vary according to tumor type.

Certain lymphomas have characteristic chromosomal translocations and molecular abnormalities.

Sarcoidosis has complex genetic susceptibility with HLA and other immune-related associations.

Most benign epithelial lacrimal gland tumors do not have a simple inherited pattern.

General Prevention

There is no reliable strategy to prevent most lacrimal gland tumors.

The most important preventive principle is appropriate management of a suspected pleomorphic adenoma, because incomplete biopsy or piecemeal excision can increase the risk of recurrence.

Etiology

Epithelial Lesions

Important epithelial lesions include:

• Dacryops
• Pleomorphic adenoma
• Adenoid cystic carcinoma
• Carcinoma ex pleomorphic adenoma
• Mucoepidermoid carcinoma
• Other adenocarcinomas

Nonepithelial Lesions

These include:

• Idiopathic inflammatory dacryoadenitis
• Lymphoma
• Reactive lymphoid hyperplasia
• Sarcoidosis
• Leukemia
• Granulomatosis with polyangiitis
• Metastatic disease
• Plasmacytoma
• Dermoid lesions
• Infectious dacryoadenitis

Commonly Associated Conditions

Lymphoma

A pink, fleshy salmon-patch conjunctival lesion may accompany ocular adnexal lymphoma.

Sjögren syndrome is associated with increased lymphoma risk.

Sarcoidosis

Associated systemic findings include:

• Pulmonary disease
• Bilateral hilar lymphadenopathy
• Uveitis
• Skin disease
• Parotid enlargement
• Cranial neuropathies

Heerfordt Syndrome

This may include:

• Parotid enlargement
• Uveitis
• Facial nerve palsy
• Fever

Löfgren Syndrome

This includes:

• Erythema nodosum
• Bilateral hilar lymphadenopathy
• Arthritis or arthralgia

Diagnosis

History

The history should focus on:

• Duration of the mass
• Rate of enlargement
• Pain
• Diplopia
• Visual decline
• Previous orbital surgery
• Previous lacrimal gland biopsy
• Previous malignancy
• Autoimmune disease
• Constitutional symptoms
• Respiratory symptoms

The pattern of symptoms often provides clues to the underlying pathology.

Clinical Patterns

Benign Epithelial Tumor

A benign epithelial tumor such as pleomorphic adenoma typically causes:

• Slow, painless progression
• Proptosis
• Inferonasal globe displacement
• Upper eyelid fullness

The course may extend over months to years.

Malignant Epithelial Tumor

Features concerning for malignancy include:

• Relatively rapid growth
• Significant pain
• Sensory disturbance
• Diplopia
• Ptosis
• Bone destruction
• Perineural symptoms
• Reduced vision

Adenoid cystic carcinoma is especially associated with pain from perineural invasion.

Inflammatory Dacryoadenitis

Inflammatory disease tends to present more abruptly with:

• Pain
• Tender upper eyelid swelling
• Redness
• Conjunctival chemosis
• Tearing
• Diplopia

The lateral upper eyelid may develop an S-shaped contour.

Lymphoma

Lymphoma often presents as:

• Painless
• Slowly progressive
• Firm lacrimal gland enlargement
• Proptosis
• Globe displacement

Bilateral disease is possible.

Physical Examination

A complete ophthalmic and orbital examination should include:

• Visual acuity
• Pupillary examination
• Color vision
• Visual fields
• Intraocular pressure
• Extraocular movements
• Eyelid position
• Proptosis measurement
• Cranial nerve examination
• Slit-lamp examination
• Dilated fundus examination

Globe Displacement

Lacrimal gland masses characteristically displace the globe inferonasally because the gland lies in the superotemporal orbit.

The degree and direction of displacement provide useful localization information.

Optic Nerve Assessment

Large or posterior lesions can compress the optic nerve.

Signs of compressive optic neuropathy include:

• Reduced visual acuity
• Dyschromatopsia
• Relative afferent pupillary defect
• Visual field loss
• Optic disc edema or pallor

Any evidence of optic nerve compromise requires urgent evaluation.

Anterior Segment Findings

Depending on the underlying disorder, slit-lamp examination may demonstrate:

• Conjunctival masses
• Conjunctival inflammation
• Episcleritis
• Scleritis
• Dry eye
• Keratic precipitates
• Anterior chamber cells and flare
• Synechiae

These findings may point toward inflammatory or systemic disease such as sarcoidosis.

Posterior Segment Findings

Possible findings include:

• Retinal vasculitis
• Peripheral vascular sheathing
• Intermediate uveitis
• Optic disc swelling

These are more suggestive of systemic inflammatory conditions than isolated epithelial tumors.

Systemic Examination

When systemic inflammatory or malignant disease is suspected, examination should look for:

• Lymphadenopathy
• Skin lesions
• Erythema nodosum
• Arthritis
• Hepatosplenomegaly
• Pulmonary signs

Diagnostic Tests and Interpretation

Laboratory Evaluation

Laboratory testing should be guided by the clinical differential rather than performed indiscriminately.

Possible tests include:

• CBC with differential
• ESR and CRP
• Serum protein electrophoresis
• ACE and other sarcoid-directed testing
• ANCA when granulomatosis with polyangiitis is suspected
• ANA when autoimmune disease is suspected
• Syphilis serology
• Tuberculosis testing

Modern sarcoidosis workup generally relies more heavily on the overall clinical picture and tissue confirmation than on ACE alone.

Orbital Imaging

CT

Orbital CT is useful for evaluating:

• Tumor location
• Bone remodeling
• Bone erosion or destruction
• Calcification
• Extension into adjacent structures

Bone destruction strongly increases concern for malignancy or aggressive inflammation.

MRI

MRI provides superior soft-tissue characterization and is useful for assessing:

• Perineural spread
• Intracranial extension
• Cavernous sinus involvement
• Orbital apex extension
• Relationship to surrounding muscles and nerves

Contrast-enhanced MRI is especially valuable when malignant disease is suspected.

Chest Imaging

Chest radiography or CT may be indicated if considering:

• Sarcoidosis
• Tuberculosis
• Metastatic disease
• Primary thoracic malignancy

Biopsy Principles

Biopsy strategy depends strongly on the suspected diagnosis.

Important Principle – Pleomorphic Adenoma

A lesion strongly suspected to be a pleomorphic adenoma should generally not undergo incisional biopsy, because violating the pseudocapsule can seed tumor cells and increase the risk of recurrence.

The preferred approach is complete intact excision when technically appropriate.

Inflammatory or Lymphoid Lesions

Biopsy is often appropriate when:

• The diagnosis is uncertain
• Lymphoma is suspected
• The lesion is atypical
• Steroid response is incomplete
• The disease recurs
• Malignancy is possible

Preferred Biopsy Site

When lacrimal gland biopsy is required, the orbital lobe is often preferred when feasible to reduce damage to the ductules of the palpebral lobe and thereby reduce postoperative dry eye.

Sarcoidosis Biopsy

Tissue may be obtained from:

• Lacrimal gland
• Conjunctiva
• Skin lesion
• Lymph node
• Pulmonary tissue

Histology demonstrates noncaseating granulomas, but infectious causes of granulomatous inflammation must be excluded.

Special stains and microbiologic testing may be necessary for:

• Mycobacteria
• Fungal organisms

Pathological Findings

Adenoid Cystic Carcinoma

Histologic patterns include:

• Cribriform
• Tubular
• Basaloid
• Solid
• Other mixed patterns

Perineural invasion is a characteristic and clinically important feature.

Pleomorphic Adenoma

Pleomorphic adenoma contains a mixture of:

• Epithelial elements
• Myoepithelial elements
• Myxoid or chondroid stroma

Sarcoidosis

Typical pathology shows noncaseating granulomas after exclusion of infection.

Idiopathic Orbital Inflammation

Pathology may show a mixed inflammatory infiltrate with:

• Lymphocytes
• Plasma cells
• Macrophages
• Variable eosinophils
• Fibrosis
• Tissue edema

Differential Diagnosis

Important differential diagnoses include:

• Pleomorphic adenoma
• Adenoid cystic carcinoma
• Lymphoma
• Reactive lymphoid hyperplasia
• Idiopathic orbital inflammation
• Sarcoidosis
• Granulomatosis with polyangiitis
• Metastatic tumor
• Leukemia
• Dermoid cyst
• Prolapsed orbital fat
• Infectious dacryoadenitis
• Perilacrimal orbital tumors

Prolapsed orbital fat can mimic lacrimal gland enlargement, particularly in older adults.

Treatment

Treatment depends entirely on the underlying diagnosis.

Pleomorphic Adenoma

The preferred treatment is complete surgical excision with the capsule intact.

Incomplete excision should be avoided because it increases the risk of:

• Recurrence
• Multifocal seeding
• Malignant transformation

Dacryops

Asymptomatic lesions may be observed.

Symptomatic or enlarging lesions may undergo:

• Marsupialization
• Complete excision

depending on location and anatomy.

Adenoid Cystic Carcinoma

Management usually requires multidisciplinary orbital oncology care.

Treatment may involve combinations of:

• Complete surgical resection when feasible
• Radiation therapy
• Systemic therapy in selected cases

The historical use of routine orbital exenteration has evolved, and modern treatment is individualized according to tumor extent, margins, perineural spread, and available eye-sparing oncologic approaches.

Lymphoma

Treatment begins with tissue diagnosis and staging.

Management may include:

• Local radiation for localized disease
• Systemic immunotherapy
• Chemotherapy
• Combined approaches

Treatment depends on lymphoma subtype and systemic involvement.

Sarcoidosis

Treatment depends on severity.

Possible approaches include:

• Observation for mild disease
• Systemic corticosteroids
• Steroid-sparing immunomodulatory therapy

Surgery is generally limited to diagnostic biopsy or selected cases requiring decompression.

Idiopathic Orbital Inflammation

Corticosteroids are commonly used when the diagnosis is sufficiently secure.

A prompt clinical response is expected in many cases.

However, lack of response, recurrence, or atypical imaging should prompt reconsideration of the diagnosis and often biopsy.

Steroid-resistant disease may require:

• Immunomodulatory therapy
• Radiation therapy
• Alternative diagnosis workup

Infectious Dacryoadenitis

Infectious causes require organism-directed treatment.

Bacterial disease may require:

• Systemic antibiotics
• Drainage if abscess develops

Steroids should not be given as stand-alone treatment if infection remains possible.

Referral

Referral may include:

• Oculoplastic/orbital surgeon
• Ocular oncologist
• Hematology/oncology
• Rheumatology
• Pulmonology
• Neurology or neurosurgery
• Infectious disease

depending on the suspected pathology.

Inpatient Considerations

Admission may be required for:

• Compressive optic neuropathy
• Rapidly progressive orbital inflammation
• Severe infection
• Intravenous corticosteroid treatment
• Orbital surgery
• Significant neurologic extension

Optic nerve dysfunction from a lacrimal gland mass requires urgent management.

Follow-Up

Follow-up depends on etiology.

Inflammatory disease may require close review during active treatment, often within days to weeks.

Malignant tumors require long-term surveillance for:

• Local recurrence
• Perineural spread
• Distant metastasis

Benign lesions that have been completely excised generally require less intensive monitoring but still need assessment for recurrence when clinically indicated.

Monitoring During Corticosteroid Therapy

Patients receiving prolonged corticosteroids should be monitored for:

• Elevated IOP
• Cataract
• Hyperglycemia
• Hypertension
• Bone loss
• Other systemic adverse effects

Coordination with primary care or relevant medical specialists is important.

Prognosis

Prognosis varies dramatically with the underlying diagnosis.

Benign Lesions

Completely excised benign epithelial tumors generally have an excellent prognosis.

Inflammatory Disease

Idiopathic inflammation and sarcoidosis often respond well to treatment but can recur.

Lymphoma

Prognosis depends on histologic subtype and systemic stage.

Adenoid Cystic Carcinoma

Adenoid cystic carcinoma has a more guarded prognosis because of:

• Perineural invasion
• Local recurrence
• Intracranial extension
• Distant metastasis

Long-term surveillance is essential.

Complications

Potential complications include:

• Proptosis
• Diplopia
• Ptosis
• Exposure keratopathy
• Dry eye after lacrimal gland surgery
• Optic neuropathy
• Vision loss
• Tumor recurrence
• Intracranial extension
• Metastatic disease

The key clinical pearl is: a slowly enlarging painless superotemporal orbital mass suggests a benign epithelial or lymphoid lesion, whereas rapid growth, pain, sensory symptoms, bone destruction, or perineural involvement should raise strong suspicion for lacrimal gland malignancy, particularly adenoid cystic carcinoma.

Ophthalmology – Keratoconus

Basics

Description

Keratoconus is a progressive, noninflammatory disorder of the cornea characterized by corneal thinning, steepening, and protrusion. As the cornea becomes increasingly irregular, it develops a cone-like shape.

The resulting optical distortion commonly causes:

• Progressive astigmatism
• Increasing myopia
• Reduced best spectacle-corrected visual acuity
• Glare and visual distortion
• Monocular diplopia
• Difficulty tolerating contact lenses
• Corneal scarring in advanced disease

The condition is usually bilateral, although one eye may be much more severely affected.

Epidemiology

Keratoconus often becomes clinically apparent during puberty or early adulthood.

The prevalence varies considerably between populations and studies, but it is generally considered an uncommon-to-moderately common corneal ectatic disorder.

Progression is usually faster in younger patients and may slow with increasing age.

Risk Factors

Important risk factors include:

• Eye rubbing
• Chronic ocular allergy
• Atopy
• Family history of keratoconus
• Repetitive mechanical pressure on the eye
• Floppy eyelid syndrome
• Sleep apnea

A first-degree relative with keratoconus increases the likelihood of developing the disease.

Genetics

Keratoconus has a genetic component, but there is no single inheritance pattern in most patients.

Familial clustering occurs, and some families show patterns compatible with incomplete autosomal dominant inheritance.

The disease is likely multifactorial, involving both genetic susceptibility and environmental or mechanical influences.

General Prevention

The most important modifiable measure is to avoid eye rubbing.

Patients with ocular allergy should receive appropriate treatment to reduce itching and the urge to rub.

Avoiding direct pressure on the cornea during sleep may also be reasonable in susceptible individuals.

Pathophysiology

Keratoconus produces progressive biomechanical weakening of the cornea.

The anterior and posterior corneal surfaces become increasingly irregular, causing:

• Irregular astigmatism
• Higher-order aberrations
• Reduced image quality

As the cornea thins and protrudes, the cone may become more pronounced.

Breaks in Bowman layer can lead to fibrosis and stromal scarring.

A rupture in Descemet membrane can allow aqueous humor to enter the corneal stroma, producing sudden severe edema known as acute corneal hydrops.

Etiology

The exact cause remains incompletely understood.

Likely contributing factors include:

• Genetic predisposition
• Abnormal corneal biomechanics
• Oxidative stress
• Enzymatic alterations within the corneal stroma
• Chronic mechanical trauma from eye rubbing

Commonly Associated Conditions

Keratoconus has been associated with:

• Floppy eyelid syndrome
• Obstructive sleep apnea
• Atopy
• Allergic conjunctivitis
• Down syndrome
• Leber congenital amaurosis
• Aniridia
• Retinopathy of prematurity
• Ehlers-Danlos syndrome
• Marfan syndrome
• Osteogenesis imperfecta

Some corneal dystrophies may also coexist.

Diagnosis

History

Patients may complain of:

• Gradually worsening vision
• Increasing astigmatism
• Frequent changes in glasses prescription
• Glare
• Halos
• Ghost images
• Monocular diplopia
• Reduced contrast sensitivity
• Difficulty driving at night
• Contact lens intolerance

The disease is commonly asymmetric.

A history of habitual eye rubbing should be specifically sought.

Some patients report pressing or rubbing one eye more than the other or sleeping predominantly on the more affected side.

Physical Examination

Refraction

Refraction may show:

• Increasing myopia
• Increasing astigmatism
• Irregular astigmatism
• Fluctuating refractive measurements

Vision may eventually become poorly correctable with spectacles.

Retinoscopy

A classic finding is a scissoring reflex due to irregular corneal curvature.

The red reflex may appear distorted or irregular.

External Signs

Advanced disease may produce visible corneal protrusion.

Munson Sign

When the patient looks downward, the cone-shaped cornea may indent the lower eyelid in a V-shaped configuration.

This is known as Munson sign.

It is generally a late finding.

Slit-Lamp Findings

Important signs include:

Fleischer Ring

An iron deposition ring around the base of the cone.

It is located in the basal epithelium and may be partial or complete.

Vogt Striae

Fine vertical lines in the deep stroma and Descemet membrane.

They often disappear temporarily when gentle external pressure is applied to the globe.

Corneal Thinning

The cornea is thinnest near the apex of the cone, which is often displaced inferiorly or inferotemporally.

Corneal Scarring

Progressive stromal stress and breaks in Bowman layer may produce:

• Apical haze
• Stromal scarring
• Dense central opacity in advanced cases

Prominent Corneal Nerves

Corneal nerves may appear unusually visible on slit-lamp examination.

Acute Corneal Hydrops

Acute hydrops occurs when Descemet membrane ruptures.

Aqueous rapidly enters the corneal stroma and causes:

• Sudden severe corneal edema
• Marked reduction in vision
• Pain or photophobia
• Epithelial bullae

Hydrops usually resolves gradually over weeks to months but may leave significant scarring.

Diagnostic Tests and Interpretation

Corneal Topography

Corneal topography is one of the most important diagnostic tests.

Typical findings include:

• Inferior or inferotemporal steepening
• High keratometric values
• Asymmetric bow-tie pattern
• Skewed radial axes
• Irregular astigmatism

Topography can detect disease before obvious slit-lamp findings appear.

Corneal Tomography

Modern tomography evaluates both the anterior and posterior corneal surfaces.

Scheimpflug-based systems such as Pentacam can demonstrate:

• Anterior elevation
• Posterior elevation
• Abnormal corneal thickness distribution
• Decentered thinnest point
• Progressive ectatic change

Posterior corneal elevation may become abnormal relatively early in the disease.

Pachymetry

Corneal thickness mapping shows:

• Localized thinning
• An abnormally displaced thinnest point
• Abnormal progression of thickness from center to periphery

Serial pachymetry is useful in monitoring progression.

Anterior-Segment OCT

Anterior-segment OCT can provide detailed maps of:

• Corneal thickness
• Epithelial thickness
• Stromal abnormalities

It can also help distinguish keratoconus from other forms of corneal irregularity.

Wavefront Aberrometry

Keratoconus produces increased higher-order aberrations, particularly vertical coma.

This helps explain why patients may have poor visual quality even when standard refractive error appears reasonably corrected.

Pathological Findings

Microscopic changes may involve all corneal layers.

Possible findings include:

• Epithelial thinning
• Degeneration of basal epithelial cells
• Iron deposition
• Breaks in Bowman layer
• Altered stromal collagen arrangement
• Stromal thinning
• Endothelial pleomorphism and polymegathism

The exact pathologic appearance varies with disease severity.

Differential Diagnosis

Important differential diagnoses include:

• Physiologic astigmatism
• Pellucid marginal degeneration
• Keratoglobus
• Post-refractive surgery ectasia
• Contact lens-induced corneal warpage
• Traumatic corneal scarring

Treatment

Management depends on:

• Severity
• Evidence of progression
• Age
• Visual needs
• Presence of scarring
• Contact lens tolerance

The goals are to improve vision and, when possible, stop progression.

Spectacles

Glasses may provide satisfactory vision in early disease when astigmatism remains relatively regular.

As irregularity increases, spectacles become less effective.

Contact Lenses

Soft Contact Lenses

Soft toric lenses may work in mild disease with relatively regular astigmatism.

Rigid Gas-Permeable Lenses

RGP lenses are commonly used because the rigid front surface provides a more regular refractive interface over the irregular cornea.

They can significantly improve vision.

Piggyback Systems

A soft lens may be worn underneath an RGP lens to improve comfort.

Hybrid Lenses

Hybrid lenses combine a rigid center with a soft peripheral skirt.

Scleral Lenses

Scleral lenses vault over the cornea and rest on the sclera.

They are particularly useful for:

• Advanced irregularity
• Contact lens intolerance
• Corneal scarring
• Severe visual distortion

Corneal Cross-Linking

Corneal collagen cross-linking is now a major treatment for progressive keratoconus.

It uses riboflavin and ultraviolet-A light to strengthen corneal collagen and increase biomechanical stability.

The primary goal is to halt or slow progression, not necessarily to restore normal corneal shape.

Cross-linking is particularly important in:

• Young patients
• Documented progression
• Increasing steepness
• Increasing refractive error
• Progressive thinning

Early treatment can reduce the likelihood of later transplantation.

Intrastromal Corneal Ring Segments

Intrastromal ring segments may be considered in selected patients.

They can:

• Flatten the cone
• Reduce irregularity
• Improve spectacle or contact lens tolerance

They do not reliably stop progression, so cross-linking may still be necessary when the disease is progressing.

Treatment of Acute Hydrops

Management is mainly supportive.

Options may include:

• Cycloplegic drops
• Hypertonic sodium chloride drops or ointment
• Lubrication
• Bandage contact lens in selected cases
• Pain control

More advanced procedures may be considered by a corneal specialist in severe hydrops.

Patients require close follow-up until the edema resolves.

Corneal Transplantation

Corneal transplantation may be necessary when there is:

• Severe corneal scarring
• Contact lens intolerance
• Advanced ectasia
• Poor functional vision despite other measures

Deep Anterior Lamellar Keratoplasty

DALK replaces the diseased corneal stroma while preserving the patient’s own endothelium.

It is often preferred when technically feasible because it avoids endothelial rejection.

Penetrating Keratoplasty

Full-thickness transplantation may be required in selected advanced cases.

Keratoconus generally has a good graft prognosis compared with many other indications for corneal transplantation.

Referral

Referral to an experienced contact lens specialist is appropriate when conventional correction is inadequate.

Referral to a corneal specialist is indicated for:

• Documented progression
• Consideration of cross-linking
• Acute hydrops
• Significant scarring
• Contact lens intolerance
• Consideration of ring segments or transplantation

Follow-Up

Stable patients should generally have periodic examinations, often at least annually.

Younger patients and those with documented progression require more frequent monitoring.

Follow-up may include:

• Refraction
• Visual acuity
• Corneal topography
• Tomography
• Pachymetry

Patients with acute hydrops may need review every few weeks until resolution.

Patient Education

Patients should be strongly advised:

• Do not rub the eyes
• Treat ocular allergy appropriately
• Attend regular corneal imaging appointments
• Report sudden visual deterioration promptly
• Understand that progression can occur even when vision seems relatively stable

Family members may also benefit from screening when there is a strong family history.

Prognosis

The clinical course is highly variable.

Some patients remain mild and stable for years, while others progress rapidly.

Progression is generally more likely in:

• Younger patients
• Eyes with steeper corneas
• Patients with significant eye rubbing
• Patients with documented serial changes

Modern cross-linking has substantially improved the ability to stabilize progressive disease.

Complications

Potential complications include:

• Progressive irregular astigmatism
• Severe visual distortion
• Contact lens intolerance
• Corneal scarring
• Acute hydrops
• Rare corneal perforation
• Need for corneal transplantation

The key clinical pearl is: keratoconus should be suspected in a young patient with progressive asymmetric myopia and astigmatism, reduced spectacle-corrected vision, and corneal topography showing inferior or inferotemporal steepening.

Ophthalmology – Kawasaki Disease

Basics

Description

Kawasaki disease (KD) is an acute, systemic medium-vessel vasculitis occurring predominantly in infants and young children.

Its greatest clinical importance is the risk of coronary artery abnormalities, particularly coronary artery aneurysms.

Classic Kawasaki disease is characterized by fever plus characteristic mucocutaneous findings:

• Bilateral nonexudative conjunctival injection
• Oral and lip changes
• Cervical lymphadenopathy
• Changes of the hands and feet
• Polymorphous rash

From an ophthalmic perspective, bilateral conjunctival injection is one of the principal diagnostic features, while mild anterior uveitis is also relatively common.

Epidemiology

Kawasaki disease occurs worldwide but has its highest incidence among children of East Asian ancestry, particularly in Japan.

Most affected children are younger than 5 years.

Other epidemiologic features include:

• Male predominance
• Peak occurrence during infancy and early childhood
• Seasonal variation in many regions

The disease is uncommon in very young neonates and older children, although it can occur at any pediatric age.

Risk Factors

Important factors include:

• Genetic susceptibility
• Young age
• Male sex
• Asian ancestry
• Family history of Kawasaki disease

A delay in diagnosis and treatment increases the risk of coronary artery complications.

Prolonged or persistent fever is also associated with greater cardiovascular risk.

Genetics

Kawasaki disease has a genetic component, but inheritance is complex.

Several susceptibility loci have been identified, including polymorphisms involving ITPKC.

Genetic susceptibility probably interacts with environmental or infectious triggers to produce the inflammatory response.

Etiology

The exact cause remains unknown.

The leading concept is that an unidentified environmental or infectious trigger produces an abnormal immune response in a genetically susceptible child.

Kawasaki disease itself is not considered a conventional contagious infection.

Pathophysiology

Kawasaki disease produces systemic vasculitis, with particularly important involvement of medium-sized muscular arteries.

The inflammatory process progresses through several stages.

Initially, there is:

• Neutrophilic infiltration
• Vascular edema
• Endothelial injury

This is followed by infiltration with:

• T lymphocytes
• Plasma cells
• Monocytes
• Macrophages

Inflammatory enzymes, including matrix metalloproteinases, can damage the arterial media and internal elastic lamina.

This weakening of the arterial wall can result in coronary artery dilation and aneurysm formation.

Later, healing may produce fibrosis, vascular remodeling, stenosis, or thrombosis.

Clinical Diagnosis

Kawasaki disease is primarily a clinical diagnosis.

The classic presentation consists of prolonged fever accompanied by the characteristic clinical features.

Fever

Fever is typically:

• High
• Persistent
• Often ≥39°C
• Poorly responsive to routine antipyretics

Untreated fever may persist for one to several weeks.

Major Clinical Features

1. Bilateral Conjunctival Injection

This is the major ophthalmic feature.

Typical findings are:

• Bilateral
• Bulbar
• Nonpurulent
• Nonexudative
• Usually painless

The conjunctival redness generally occurs without the thick discharge typical of bacterial conjunctivitis.

2. Oral and Oropharyngeal Changes

Typical findings include:

• Bright red lips
• Dry or cracked lips
• Diffuse oral mucosal erythema
• Strawberry tongue

Oral ulceration and exudative tonsillitis are not typical and should suggest alternative diagnoses.

3. Cervical Lymphadenopathy

Usually:

• Nonpurulent
• Cervical
• Often unilateral

At least one lymph node may be markedly enlarged.

This is generally the least frequently encountered of the classic diagnostic features.

4. Extremity Changes

During the acute phase:

• Erythema of palms and soles
• Edema of hands and feet

During the subacute phase:

• Periungual desquamation of fingers and toes

Peeling typically begins approximately 1–3 weeks after disease onset.

5. Polymorphous Rash

A generalized rash commonly involves the trunk and extremities.

It may have several appearances but is generally nonvesicular.

Perineal erythema and subsequent desquamation may also occur.

Ocular Manifestations

Conjunctival Injection

Bilateral nonexudative conjunctival injection is one of the defining clinical manifestations of Kawasaki disease.

It usually resolves as the systemic inflammatory process improves.

Anterior Uveitis

Kawasaki disease can produce a mild bilateral anterior uveitis.

Slit-lamp examination may demonstrate:

• Anterior chamber cells
• Mild flare

The uveitis is generally:

• Mild
• Transient
• Bilateral
• Self-limited

It usually improves as the systemic disease is treated.

Topical corticosteroids are usually unnecessary, although ophthalmic treatment may be required when inflammation is more significant.

Other Ocular Manifestations

Less common manifestations include:

• Superficial punctate keratitis
• Choroiditis
• Optic disc swelling
• Other posterior segment inflammatory abnormalities

Severe ocular disease is unusual.

Associated Systemic Findings

Kawasaki disease may also produce:

• Marked irritability
• Arthritis or arthralgia
• Myocarditis
• Pericarditis
• Gastrointestinal symptoms
• Abdominal pain
• Vomiting
• Diarrhea
• Hepatitis
• Gallbladder hydrops
• Sterile pyuria
• Aseptic meningitis
• Otitis media

The major concern remains cardiovascular involvement.

Coronary Artery Disease

The most important complication is coronary artery involvement.

Possible abnormalities include:

• Coronary dilation
• Coronary aneurysm
• Giant coronary aneurysm
• Coronary thrombosis
• Coronary stenosis
• Myocardial ischemia
• Myocardial infarction

Untreated Kawasaki disease has a substantial risk of coronary artery abnormalities.

Prompt treatment with IVIG dramatically reduces this risk.

Diagnostic Testing

There is no single laboratory test that confirms Kawasaki disease.

Laboratory investigations support the diagnosis and help assess disease severity.

Common abnormalities include:

• Elevated CRP
• Elevated ESR
• Leukocytosis with neutrophilia
• Normocytic anemia
• Elevated hepatic transaminases
• Hypoalbuminemia
• Sterile pyuria

Platelet counts may initially be normal.

During the subacute phase, thrombocytosis commonly develops.

Cardiac Evaluation

Echocardiography

Echocardiography is essential for evaluating:

• Coronary artery dimensions
• Coronary aneurysms
• Ventricular function
• Pericardial effusion
• Other cardiac abnormalities

Importantly, a normal early echocardiogram does not exclude Kawasaki disease.

Serial cardiac imaging is determined by the patient’s coronary findings and clinical course.

Ophthalmic Examination

Routine ophthalmologic consultation is not necessary for every uncomplicated case.

An ophthalmic examination is particularly appropriate when there is:

• Suspected anterior uveitis
• Significant photophobia
• Reduced vision
• Persistent ocular inflammation
• Atypical ocular manifestations

Slit-lamp examination can detect mild anterior chamber inflammation that is not obvious externally.

Differential Diagnosis

Important differential diagnoses include:

• Adenovirus infection
• Scarlet fever
• Toxic shock syndrome
• Measles
• Drug hypersensitivity reactions
• Stevens–Johnson syndrome
• Systemic juvenile idiopathic arthritis
• Other systemic vasculitides
• Bacterial cervical lymphadenitis

Adenovirus can be particularly confusing because both conditions can produce fever and conjunctival injection.

However, exudative conjunctivitis and pharyngitis favor adenovirus rather than classic Kawasaki disease.

Incomplete Kawasaki Disease

Some children do not meet all of the classic clinical criteria but still have Kawasaki disease.

This is known as incomplete Kawasaki disease.

It is especially important to consider in:

• Young infants
• Children with prolonged unexplained fever
• Patients with compatible laboratory abnormalities
• Patients with coronary artery abnormalities

Incomplete disease can still cause serious coronary complications and should not be considered a mild form of Kawasaki disease.

Treatment

Intravenous Immunoglobulin

IVIG is the cornerstone of treatment.

Standard initial therapy is:

IVIG 2 g/kg as a single infusion.

Treatment should be administered promptly once the diagnosis is established.

Early IVIG substantially reduces the risk of coronary artery aneurysm formation.

Aspirin

Aspirin is traditionally given during the acute inflammatory phase, followed by low-dose antiplatelet aspirin.

Low-dose aspirin is generally continued until follow-up confirms the absence of clinically important coronary abnormalities.

Patients with persistent coronary artery abnormalities may require longer antiplatelet therapy.

Exact aspirin dosing and duration should follow current pediatric cardiology/Kawasaki disease protocols.

IVIG-Resistant Disease

Some children have persistent or recurrent fever after initial IVIG.

Depending on the clinical situation, additional treatment may include:

• Repeat IVIG
• Systemic corticosteroids
• Infliximab
• Other immunomodulatory therapy

High-risk children may receive corticosteroids as part of initial therapy rather than waiting for IVIG resistance.

Antithrombotic Therapy

Children with significant coronary aneurysms may require more intensive thrombosis prevention.

Depending on aneurysm size and other risk factors, treatment may include:

• Aspirin
• Additional antiplatelet agents
• Anticoagulation

Management should be directed by pediatric cardiology.

Treatment of Ocular Disease

The conjunctival injection generally requires no specific ocular treatment.

Mild anterior uveitis typically resolves with systemic treatment.

More significant anterior uveitis may occasionally require:

• Topical corticosteroids
• Cycloplegic agents

These should be managed by an ophthalmologist.

Hospital Management

Children with suspected acute Kawasaki disease generally require hospital evaluation and treatment.

Management includes:

• IVIG
• Anti-inflammatory/antiplatelet therapy
• Cardiac assessment
• Laboratory monitoring
• Echocardiography

Fluid management may be necessary in children with significant gastrointestinal symptoms or dehydration.

Follow-Up

Long-term follow-up depends predominantly on coronary artery involvement.

Children without coronary abnormalities generally require substantially less intensive long-term cardiac surveillance than children with persistent aneurysms.

Patients with coronary aneurysms may require:

• Serial echocardiography
• ECG
• Additional coronary imaging
• Stress testing
• Long-term antithrombotic therapy

Large or giant aneurysms require particularly close lifelong cardiology surveillance.

Ophthalmology Follow-Up

Ophthalmic follow-up is primarily indicated when:

• Anterior uveitis is present
• Ocular inflammation persists
• Vision is reduced
• Atypical ocular manifestations develop

Most conjunctival and mild inflammatory ocular manifestations resolve without permanent visual consequences.

Prognosis

With prompt diagnosis and appropriate treatment, the prognosis is generally excellent.

IVIG dramatically decreases the frequency of coronary artery aneurysms.

Long-term prognosis is primarily determined by the presence, size, and persistence of coronary artery abnormalities.

Complications

The major complications are cardiovascular:

• Coronary artery aneurysm
• Coronary thrombosis
• Coronary stenosis
• Myocardial ischemia
• Myocardial infarction
• Arrhythmia
• Rare sudden cardiac death

The key ophthalmology pearl is: bilateral, nonpurulent conjunctival injection in a persistently febrile young child—particularly when accompanied by strawberry tongue, rash, extremity changes, or cervical lymphadenopathy—should immediately raise suspicion for Kawasaki disease.

Ophthalmology – Juvenile Xanthogranuloma (Nevoxanthoendothelioma)

Basics

Description

Juvenile xanthogranuloma (JXG) is a benign non-Langerhans cell histiocytic disorder that occurs mainly in infants and young children.

It is usually a self-limited skin disease, producing yellow-tan papules or nodules on the head, neck, trunk, or extremities.

Extracutaneous involvement occurs in a small percentage of patients and may involve:

• Eye
• Lung
• Gastrointestinal tract
• Bone
• Muscle

Ocular involvement can affect:

• Iris
• Eyelid
• Cornea
• Conjunctiva
• Ciliary body
• Choroid
• Episclera
• Orbit
• Posterior segment

The iris is the most important ocular site, because involvement can cause spontaneous hyphema and secondary glaucoma.

Epidemiology

The true incidence of JXG is uncertain because many cutaneous lesions regress spontaneously and may never be diagnosed.

Most cases occur in early childhood.

Approximately:

• 10% are present at birth
• Most develop during the first year of life
• Solitary skin lesions are more common than multiple lesions

Ocular disease occurs predominantly in very young children and is usually unilateral.

Only about half of children with ocular JXG have obvious skin lesions, so absence of a cutaneous lesion does not exclude ocular disease.

Pathophysiology

JXG is believed to result from a reactive proliferation of histiocytes rather than a true neoplasm.

The trigger is uncertain but may involve a nonspecific inflammatory response to physical or infectious stimuli.

Affected tissues accumulate:

• Histiocytes
• Lipid-laden foam cells
• Multinucleated giant cells

The characteristic histologic cell is the Touton giant cell.

Commonly Associated Conditions

Important associations include:

Neurofibromatosis Type 1

JXG may occur in children with NF1.

Children with the combination of:

• NF1
• JXG

have historically been recognized as having an increased association with juvenile myelomonocytic leukemia, although the magnitude of this association varies among studies.

Juvenile Myelomonocytic Leukemia

JMML is a rare myeloproliferative disorder of early childhood.

Because iris infiltration from leukemia can mimic ocular JXG, atypical cases require careful systemic evaluation.

Niemann–Pick Disease

Rarely associated with xanthomatous lesions and systemic storage disease.

Urticaria Pigmentosa

A form of cutaneous mastocytosis that may coexist with other pediatric dermatologic lesions.

Diagnosis

History

Many children are asymptomatic.

Parents may notice:

• Yellow-orange skin nodules
• Change in iris color
• Red eye
• Visible blood in the eye
• Enlarged pupil
• Reduced vision
• Eye pain
• Photophobia

Pain and photophobia may occur when secondary glaucoma develops.

Because children may not report visual symptoms reliably, careful examination is essential.

Cutaneous Findings

Typical skin lesions are:

• Firm
• Tan, yellow, orange, or reddish
• Papular or nodular
• Usually located on the head, neck, trunk, or extremities

They may be solitary or multiple.

Most lesions gradually regress spontaneously.

Ocular Findings

Ocular JXG may produce:

• Spontaneous hyphema
• Vascular yellow-brown iris mass
• Heterochromia
• Unilateral anterior uveitis
• Secondary glaucoma
• Corneal blood staining
• Cataract
• Conjunctival mass
• Proptosis
• Retinal vascular occlusion
• Retinal detachment
• Amblyopia

A young child with unilateral spontaneous hyphema and glaucoma should prompt consideration of JXG.

Iris Involvement

The iris may appear:

• Thickened
• Diffusely infiltrated
• Nodular
• Yellow-brown
• Highly vascular

Fragile abnormal vessels can bleed spontaneously, causing hyphema.

Iris infiltration may also obstruct the anterior chamber angle and elevate IOP.

Secondary Glaucoma

Glaucoma may result from:

• Obstruction of the trabecular meshwork by inflammatory or histiocytic material
• Peripheral anterior synechiae
• Blood in the anterior chamber
• Steroid response
• Structural angle damage

This is one of the most important causes of visual loss in ocular JXG.

Physical Examination

A complete examination should include:

• Skin examination of head, neck, trunk, and extremities
• Visual acuity assessment
• Pupillary examination
• Intraocular pressure
• Slit-lamp examination
• Gonioscopy when feasible
• Dilated fundus examination

In young children, examination under anesthesia may occasionally be required.

Diagnostic Tests

Biopsy

Diagnosis can be confirmed by biopsy of:

• Skin lesion
• Iris lesion
• Other involved tissue

For iris disease, biopsy options may include:

• Fine-needle aspiration
• Iridectomy
• Iridocyclectomy

Biopsy is generally reserved for cases in which the clinical diagnosis is uncertain or malignancy cannot be excluded.

Pathological Findings

Classic histology demonstrates:

• Histiocytes
• Foam cells
• Lymphocytes
• Plasma cells
• Multinucleated giant cells

The characteristic finding is the Touton giant cell.

Touton giant cells contain a ring of nuclei surrounded by foamy, lipid-containing cytoplasm.

Immunohistochemistry typically shows positivity for histiocytic markers such as:

• CD68
• CD163
• Factor XIIIa

Cells are generally negative for:

• CD1a
• S-100

This helps distinguish JXG from Langerhans cell histiocytosis.

Differential Diagnosis

Important differential diagnoses include:

• Leukemic iris infiltration
• Iris nevus
• Iris melanoma
• Langerhans cell histiocytosis
• Rhabdomyosarcoma
• Dermoid
• Xanthoma
• Hemangioma
• Neurofibroma
• Molluscum contagiosum
• Juvenile idiopathic arthritis-associated uveitis

The combination of a vascular iris lesion, spontaneous hyphema, and secondary glaucoma in a young child is especially suggestive of JXG.

Treatment

Treatment depends on the site and severity of disease.

Many cutaneous lesions require no treatment because they regress spontaneously.

Ocular disease requires more aggressive management because of the risk of permanent visual loss.

Corticosteroids

Systemic corticosteroids may be used for significant ocular or extracutaneous disease.

Topical corticosteroids may be used for associated anterior segment inflammation.

In selected refractory cases, additional immunomodulatory therapy may be considered.

Management of Hyphema

Spontaneous hyphema should be treated with standard precautions.

Management may include:

• Cycloplegic drops
• Topical corticosteroids
• Eye shield
• Head elevation
• Avoidance of strenuous activity
• Avoidance of unnecessary anticoagulant or antiplatelet exposure

IOP should be monitored closely.

Management of Glaucoma

Elevated IOP should be treated promptly.

Initial treatment may include topical pressure-lowering medications.

If glaucoma is severe or uncontrolled, surgical management may be necessary.

Because these are young children, prolonged elevation of IOP can cause rapid and permanent optic nerve damage.

Amblyopia Treatment

Amblyopia is an important secondary complication.

It can result from:

• Cataract
• Corneal blood staining
• Strabismus
• Anisometropia
• Glaucoma
• Prolonged visual deprivation

Treatment may include:

• Refractive correction
• Patching
• Atropine penalization
• Treatment of the underlying ocular lesion

Early treatment is essential.

Surgery

Surgical procedures may be required for:

• Local resection of persistent lesions
• Cataract extraction
• Glaucoma surgery
• Removal of visually significant iris or conjunctival masses

Surgery is individualized according to the affected structure and visual threat.

Follow-Up

Children with ocular JXG should be followed by an ophthalmologist, often with pediatric ophthalmology involvement.

Monitoring should include:

• Visual acuity
• IOP
• Anterior chamber inflammation
• Hyphema recurrence
• Cataract
• Corneal blood staining
• Optic nerve appearance
• Amblyopia

A primary care physician or dermatologist should follow associated skin lesions.

Patient Education

Parents should understand that most skin lesions are benign and self-limited.

However, ocular involvement can be serious.

They should seek prompt ophthalmic evaluation for:

• Red eye
• Eye pain
• Photophobia
• Visible blood in the eye
• Change in iris color
• New squint
• Reduced visual behavior

Prognosis

The systemic prognosis is generally excellent.

Most children have:

• Normal development
• Normal intelligence
• Normal lifespan
• Spontaneous regression of cutaneous lesions

The ocular prognosis depends on early recognition and control of complications.

Vision can be permanently reduced if secondary glaucoma, cataract, corneal blood staining, or amblyopia develops.

Complications

Important complications include:

• Secondary glaucoma
• Recurrent hyphema
• Corneal blood staining
• Cataract
• Amblyopia
• Retinal detachment
• Severe permanent visual loss

The key clinical pearl is: a young child with unilateral spontaneous hyphema, a vascular yellow-brown iris lesion, and secondary glaucoma should raise strong suspicion for juvenile xanthogranuloma.

Ophthalmology – Juvenile Idiopathic Arthritis-Related Uveitis

Basics

Description

Juvenile idiopathic arthritis (JIA)-related uveitis is an important cause of chronic anterior uveitis in children with juvenile idiopathic arthritis.

JIA is defined as arthritis beginning before 16 years of age, persisting for more than 6 weeks, and occurring without another identifiable cause.

The major JIA categories include:

• Systemic arthritis
• Oligoarthritis
• Rheumatoid factor-negative polyarthritis
• Rheumatoid factor-positive polyarthritis
• Psoriatic arthritis
• Enthesitis-related arthritis
• Undifferentiated arthritis

Among these, oligoarticular JIA carries the greatest classic risk of chronic asymptomatic anterior uveitis.

A major clinical problem is that the eye may remain white and painless despite significant intraocular inflammation.

Epidemiology

The exact incidence and prevalence of JIA vary widely among populations.

Reported incidence ranges from approximately 0.008 to 0.226 per 1,000 children per year.

Reported prevalence ranges from approximately 0.07 to 4 per 1,000 children.

Uveitis develops in a minority of children with JIA, but the proportion varies substantially by population and JIA subtype.

Overall, approximately 8–10% of children with JIA develop uveitis, although individual studies have reported much wider ranges.

Risk Factors

Important risk factors for JIA-associated uveitis include:

• Positive ANA
• Young age at onset of arthritis
• Female sex
• Oligoarticular disease
• Early duration after JIA diagnosis

Children who develop arthritis at a younger age generally carry a greater risk than those with later-onset disease.

Genetics

JIA is genetically complex.

Certain HLA associations have been reported.

HLA-DRB1 alleles have been linked with susceptibility to JIA, and some studies have associated HLA-DRB1*13 with increased risk of uveitis.

No single genetic abnormality explains JIA-related uveitis.

Pathophysiology

The exact mechanism is not fully understood.

JIA is considered an immune-mediated inflammatory disease involving abnormal regulation of both innate and adaptive immunity.

Autoantibodies such as:

• ANA
• Rheumatoid factor
• Anti-cyclic citrullinated peptide antibodies

may be present in some patients, but the exact ocular antigen responsible for uveitis remains unknown.

Persistent inflammation within the anterior chamber can damage multiple ocular structures over time.

Etiology

The precise cause is unknown.

JIA-related uveitis is believed to result from a combination of:

• Genetic susceptibility
• Immune dysregulation
• Environmental triggers

JIA Subtypes

Systemic JIA

Systemic arthritis involves one or more joints with fever and may be associated with:

• Evanescent rash
• Generalized lymphadenopathy
• Hepatomegaly
• Splenomegaly
• Serositis

This subtype has a relatively low risk of chronic uveitis.

Oligoarthritis

Oligoarthritis affects 1–4 joints during the first 6 months.

It is divided into:

• Persistent oligoarthritis
• Extended oligoarthritis

This subtype is particularly important because it carries one of the highest risks of chronic asymptomatic uveitis.

Polyarthritis

Polyarthritis affects 5 or more joints during the first 6 months.

It is divided into:

• RF-negative polyarthritis
• RF-positive polyarthritis

Uveitis risk is generally lower than in oligoarticular JIA.

Psoriatic Arthritis

This category includes arthritis with psoriasis or arthritis associated with features such as:

• Dactylitis
• Nail pitting
• Onycholysis
• First-degree relative with psoriasis

Uveitis can occur.

Enthesitis-Related Arthritis

ERA is associated with inflammation at tendon or ligament insertions.

Features may include:

• Sacroiliac tenderness
• HLA-B27 positivity
• Male sex with onset after age 6
• Acute symptomatic anterior uveitis
• Family history of ankylosing spondylitis or related disorders

Unlike classic JIA-associated chronic uveitis, ERA-associated uveitis is often acute, painful, red, and photophobic.

Undifferentiated Arthritis

This includes children who do not clearly meet criteria for a single category or fulfill criteria for multiple categories.

Diagnosis

History

Many children with JIA-related uveitis have no ocular symptoms at all.

This is the reason regular ophthalmic screening is mandatory.

When symptoms are present, ask about:

• Decreased vision
• Photophobia
• Redness
• Eye pain
• Previous episodes labeled as “pink eye”
• Floaters

The absence of symptoms does not rule out active disease.

Clinical Classification

Using standard uveitis terminology, anterior inflammation may be described as:

Acute Anterior Uveitis

Sudden-onset anterior uveitis of limited duration.

Recurrent Anterior Uveitis

Repeated episodes separated by periods of inactivity without treatment.

Chronic Anterior Uveitis

Inflammation persisting for more than approximately 3 months or recurring quickly when treatment is stopped.

This is the classic form seen with JIA.

Anterior Uveitis With Vitreous Involvement

Anterior inflammation may occasionally be associated with true vitreous inflammatory cells.

Physical Examination

JIA-related uveitis is usually:

• Anterior
• Chronic
• Nongranulomatous
• Bilateral or eventually bilateral

Both eyes may become involved within months of one another.

Although traditionally considered nongranulomatous, some children can show granulomatous features.

Anterior Chamber Findings

Slit-lamp examination may demonstrate:

• Inflammatory cells
• Flare
• Posterior synechiae

Treatment decisions should be guided primarily by the cellular inflammatory activity, not by flare alone.

Persistent flare may reflect chronic breakdown of the blood-aqueous barrier even after active cellular inflammation has improved.

Posterior Synechiae

Posterior synechiae occur when the posterior iris adheres to the anterior lens capsule.

They can lead to:

• Irregular pupil
• Poor dilation
• Pupillary block
• Secondary angle closure

Preventing synechiae is an important treatment goal.

Band Keratopathy

Band keratopathy is a classic complication of chronic pediatric uveitis.

Calcium deposits accumulate within the superficial cornea, typically across the interpalpebral zone.

Severe band keratopathy may reduce vision and cause discomfort.

Cataract

Cataract is one of the most important vision-threatening complications.

It can result from:

• Chronic inflammation
• Corticosteroid treatment
• Posterior synechiae

Posterior subcapsular cataract is particularly common.

Glaucoma

Secondary glaucoma may develop from:

• Chronic inflammation
• Peripheral anterior synechiae
• Steroid response
• Trabecular damage
• Angle closure

Glaucoma can be difficult to detect in children and may progress silently.

Hypotony

Severe chronic inflammation can impair ciliary body function and lead to ocular hypotony.

Longstanding hypotony can produce:

• Maculopathy
• Structural ocular damage
• Phthisis bulbi in severe cases

Cystoid Macular Edema

CME is an important cause of decreased vision.

OCT should be obtained when central visual acuity is reduced or macular involvement is suspected.

Diagnostic Tests

Laboratory Testing

There is no laboratory test that confirms JIA-related uveitis.

JIA remains a clinical diagnosis of exclusion.

When the systemic diagnosis has not already been established, investigations may include:

• ESR
• CRP
• Platelet count
• ANA
• RF
• Anti-CCP

Testing for alternative causes may be considered when the presentation is atypical, including:

• Lyme disease
• Sarcoidosis
• Tuberculosis
• Other infectious or inflammatory disorders

Optical Coherence Tomography

OCT is particularly useful when:

• Visual acuity is reduced
• CME is suspected
• Macular structural damage needs monitoring

It provides an objective method of monitoring macular response to treatment.

Differential Diagnosis

The most important differential diagnoses include:

• Sarcoidosis
• Lyme disease
• Herpetic keratouveitis
• Trauma
• Kawasaki disease
• Other pediatric inflammatory conditions

Sarcoidosis can closely resemble JIA-associated uveitis and should be considered in atypical or granulomatous cases.

Treatment Goals

The goals are to:

• Eliminate active inflammation
• Prevent synechiae
• Preserve vision
• Minimize corticosteroid toxicity
• Prevent cataract and glaucoma
• Maintain long-term quiescence

Because children may need years of treatment, long-term safety is especially important.

First-Line Treatment

Topical Corticosteroids

Topical corticosteroids are first-line treatment for active anterior uveitis.

The dose is adjusted according to:

• Anterior chamber cell count
• Severity of inflammation
• Presence of synechiae
• Response to treatment

The goal is to achieve complete control while using the lowest effective steroid exposure.

Persistent need for frequent topical corticosteroid dosing suggests the need for steroid-sparing systemic therapy.

Cycloplegics and Mydriatics

Short-acting cycloplegics are used to:

• Prevent posterior synechiae
• Relieve ciliary spasm
• Reduce pain
• Maintain pupillary mobility

Long-term continuous cycloplegia should be used thoughtfully because blur and amblyopia can be important issues in young children.

Periocular Corticosteroids

Periocular steroid injections may occasionally be used for severe or refractory inflammation.

However, they carry significant risks, particularly:

• Cataract
• Ocular hypertension
• Glaucoma

They are therefore used selectively.

Systemic Corticosteroids

Oral or intravenous corticosteroids may be used for severe disease, but prolonged systemic steroid therapy should generally be avoided in children because of:

• Growth suppression
• Bone effects
• Metabolic complications
• Immune suppression

They are often used as temporary bridging therapy rather than as the primary long-term strategy.

Methotrexate

Methotrexate is a major first-line steroid-sparing systemic treatment for JIA-associated uveitis.

It is especially useful when:

• Topical corticosteroids cannot be reduced adequately
• Inflammation remains active
• Bilateral chronic disease is present
• Steroid toxicity is developing

Clinical response may take several weeks.

Monitoring generally includes:

• CBC
• Liver function tests

The exact monitoring schedule is coordinated with pediatric rheumatology.

Biologic Therapy

Biologic agents are important for disease that is inadequately controlled with conventional therapy.

Adalimumab

Adalimumab is strongly established as an effective therapy for JIA-associated uveitis, particularly when methotrexate alone is insufficient.

Infliximab

Infliximab can also be effective in selected refractory cases.

Etanercept

Although effective for joint disease, etanercept is not considered an effective treatment for JIA-associated uveitis and is generally not preferred when ocular inflammation is a major concern.

Other Immunomodulatory Agents

Additional steroid-sparing treatments may include:

• Mycophenolate mofetil
• Azathioprine
• Cyclosporine
• Tacrolimus

Choice depends on disease severity, response, systemic manifestations, and specialist experience.

Surgical Treatment

Cataract Surgery

Cataract is a frequent complication.

Modern management may include:

• Phacoemulsification
• Posterior capsulotomy or capsulorrhexis
• Anterior vitrectomy when appropriate
• Intraocular lens implantation in selected well-controlled cases

The most important principle is that uveitis should be well controlled before cataract surgery whenever possible.

Poorly controlled inflammation increases the risk of severe postoperative complications.

Glaucoma Surgery

When topical medications fail, surgical options may include:

• Trabeculectomy with antimetabolite
• Glaucoma drainage device

Glaucoma surgery in uveitic children can be challenging and often requires specialist management.

Band Keratopathy Treatment

Visually significant or symptomatic band keratopathy may be treated with EDTA chelation.

Recurrence can occur, particularly if inflammation remains active.

Ongoing Care

Follow-Up Recommendations

Children with JIA should undergo scheduled ophthalmic screening according to:

• Age at arthritis onset
• JIA subtype
• ANA status
• Duration of disease
• Previous history of uveitis

Screening is essential even when the child has no eye symptoms.

Patient Monitoring

Monitoring should include:

• Visual acuity
• Amblyopia assessment
• Slit-lamp examination
• Anterior chamber cell grading
• IOP measurement
• Lens evaluation
• Corneal evaluation
• Posterior segment examination
• OCT when indicated

Systemic medication toxicity must also be monitored.

Multidisciplinary Care

Management ideally involves:

• Pediatric ophthalmologist
• Pediatric rheumatologist
• Uveitis specialist when necessary

Close communication between specialists is important because arthritis activity and ocular inflammation can behave independently.

Patient and Parent Education

Parents should understand that JIA-associated uveitis is often completely asymptomatic.

A child can have serious intraocular inflammation despite:

• No pain
• No redness
• No photophobia
• No obvious visual complaint

Therefore, scheduled screening visits should not be skipped simply because the eyes appear normal.

Any episode of persistent red eye in a child with JIA should be evaluated rather than automatically assumed to be viral conjunctivitis.

Prognosis

Modern outcomes have improved significantly with:

• Earlier screening
• Aggressive control of inflammation
• Steroid-sparing immunomodulatory therapy
• Biologic treatment

Many children can retain excellent functional vision when disease is identified early and controlled adequately.

Delayed diagnosis and longstanding inflammation increase the risk of irreversible visual loss.

Complications

Important complications include:

• Cataract
• Band keratopathy
• Posterior synechiae
• Secondary glaucoma
• Cystoid macular edema
• Hypotony
• Amblyopia
• Permanent visual loss
• Phthisis bulbi in severe end-stage disease

The key clinical pearl is: JIA-related uveitis can be severe in a completely white, quiet, asymptomatic eye, so routine slit-lamp screening is essential for children at risk.

Ophthalmology – Isolated Trochlear Nerve (Cranial Nerve IV) Palsy

Basics

Description

A trochlear nerve, or cranial nerve IV, palsy causes weakness or paralysis of the superior oblique muscle.

The superior oblique primarily contributes to:

• Depression of the eye in adduction
• Intorsion
• Abduction to a lesser degree

When the trochlear nerve is weak, patients typically develop vertical or oblique binocular diplopia, often worse when looking downward.

Epidemiology

Trochlear nerve palsy is relatively common after closed head trauma.

The trochlear nerve is particularly vulnerable because it:

• Has a long intracranial course
• Exits dorsally from the brainstem
• Decussates before reaching the orbit

These anatomic features make it susceptible to traumatic injury.

Etiology

Common causes include:

• Congenital trochlear nerve palsy
• Head trauma
• Microvascular ischemia

Less common causes include:

• Tumors
• Pineal region lesions
• Tentorial meningioma
• Aneurysm
• Meningitis
• Giant cell arteritis

In adults, vascular risk factors such as diabetes and hypertension may contribute to microvascular trochlear nerve palsy.

Congenital Trochlear Nerve Palsy

Congenital fourth nerve palsy is common and may not become symptomatic until later in life.

Patients may have compensated for the deviation for years with a habitual head tilt.

Old photographs can be very helpful.

A longstanding head tilt away from the affected side in childhood photographs strongly supports a congenital palsy.

Decompensation may occur later because of:

• Aging
• Illness
• Fatigue
• Reduced fusional reserves
• Trauma

Diagnosis

History

Patients usually complain of binocular vertical or diagonal diplopia.

Symptoms are classically worse when:

• Looking downward
• Reading
• Walking downstairs
• Looking down while eating

Some patients describe the image in the affected eye as appearing tilted or rotated.

A characteristic compensatory maneuver is tilting the head away from the affected side, which reduces the vertical separation of the images.

Physical Examination

Superior Oblique Weakness

The affected eye has difficulty depressing when it is adducted.

This is often most apparent when the patient looks:

• Toward the opposite side
• Then downward

The ipsilateral inferior oblique may appear relatively overactive, producing overelevation in adduction.

Hypertropia

The eye affected by a fourth nerve palsy is usually hypertropic.

The hypertropia is generally greatest when:

• Looking toward the opposite side
• Tilting the head toward the affected side

This pattern helps localize the involved superior oblique muscle.

Head Tilt

Patients commonly adopt a compensatory head tilt away from the palsied side.

For example, with a right fourth nerve palsy, the patient may tilt the head to the left.

This reduces diplopia and allows better binocular fusion.

Bielschowsky Head-Tilt Test

The vertical deviation usually increases when the head is tilted toward the side of the palsy.

This occurs because head tilt normally stimulates intorting muscles. In a weak superior oblique, the eye cannot intort properly, and the unopposed elevators produce greater hypertropia.

This is an important component of the classic diagnostic pattern.

Three-Step Test

The traditional Parks–Bielschowsky three-step test can help identify a fourth nerve palsy.

The clinician determines:

1. Which eye is hypertropic in primary gaze
2. In which horizontal gaze the hypertropia increases
3. With which head tilt the hypertropia increases

The resulting pattern can help identify the paretic superior oblique.

However, real-world cases may not always follow the classic pattern perfectly.

Vertical Fusional Amplitude

Patients with congenital trochlear nerve palsy often develop unusually large vertical fusional amplitudes.

A vertical fusional amplitude greater than approximately 3 prism diopters supports a longstanding congenital deviation rather than a newly acquired palsy.

Ptosis

A true isolated fourth nerve palsy does not cause ptosis.

A patient may voluntarily close one eye to eliminate diplopia, but actual levator weakness suggests another diagnosis.

Diagnostic Tests and Interpretation

Laboratory Evaluation

In adults with possible microvascular disease, evaluation may include:

• Blood pressure
• Fasting glucose
• HbA1c
• Lipid profile

If symptoms suggest giant cell arteritis, particularly in an older adult, inflammatory markers and urgent systemic evaluation are indicated.

Imaging

A typical isolated fourth nerve palsy with a clear congenital, traumatic, or microvascular explanation may not always require immediate imaging.

However, neuroimaging should be considered when:

• The palsy is atypical
• Other neurologic findings are present
• There is progressive worsening
• There is no improvement after several months
• A tumor or structural lesion is suspected

MRI is generally preferred for evaluating brainstem, cavernous sinus, and posterior fossa disease.

Differential Diagnosis

Bilateral Fourth Nerve Palsy

Bilateral trochlear palsies are particularly associated with trauma.

Clues include:

• Alternating hypertropia depending on gaze
• Large excyclotorsion
• V-pattern esotropia
• Chin-down posture
• Bilateral superior oblique underaction

Bilateral cases can be more difficult to recognize than unilateral palsy.

Myasthenia Gravis

Ocular myasthenia can mimic almost any ocular motor nerve palsy.

Clues include:

• Variable ptosis
• Fatigability
• Changing alignment
• Diurnal variation
• Inconsistent motility pattern

Pupillary function remains normal.

Thyroid Eye Disease

Graves orbitopathy can produce vertical diplopia from restrictive extraocular muscle disease.

Associated findings may include:

• Lid retraction
• Proptosis
• Conjunctival chemosis
• Restrictive motility
• Abnormal thyroid studies

Restriction of the inferior rectus can especially mimic a superior oblique palsy.

Skew Deviation

Skew deviation is a supranuclear vertical strabismus caused by imbalance in vestibular pathways.

It may occur with:

• Brainstem stroke
• Cerebellar disease
• Other central neurologic disorders

Features favoring skew include:

• Associated neurologic signs
• Ocular torsion pattern inconsistent with fourth nerve palsy
• Reduction of vertical deviation when supine in some cases

Superior Oblique Myokymia

Superior oblique myokymia causes brief, recurrent episodes of:

• Monocular oscillopsia
• Vertical movement
• Torsional movement
• Image tilting

It may result from neurovascular compression of the fourth nerve root exit zone, multiple sclerosis, or rarely posterior fossa lesions.

It differs from trochlear palsy because symptoms are episodic rather than a persistent weakness.

Giant Cell Arteritis

GCA can rarely cause an ocular motor palsy.

In older patients, ask about:

• New headache
• Scalp tenderness
• Jaw claudication
• Weight loss
• Polymyalgia symptoms

If suspected, urgent treatment and systemic evaluation are required.

Treatment

General Measures

Many patients can reduce symptoms by adopting a compensatory head tilt away from the affected side.

This is a natural adaptation and may be sufficient in mild cases.

Prism Glasses

Prisms can be very useful for persistent vertical or diagonal diplopia, particularly when the deviation is relatively small and stable.

Options include:

• Temporary Fresnel prisms
• Ground-in prisms for stable deviations

Prisms are often more successful in fourth nerve palsy than in third nerve palsy because the deviation may be more manageable in primary gaze.

Occlusion

If torsional or vertical diplopia cannot be controlled with prism, temporary occlusion can be used.

Options include:

• Eye patch
• Frosted spectacle lens
• Translucent tape on one lens

This eliminates diplopia but sacrifices binocular vision.

Management of Vascular Risk Factors

In presumed microvascular palsy, optimize:

• Blood pressure
• Blood glucose
• Lipid levels
• Smoking status
• Overall cardiovascular health

Referral

Any persistent, progressive, atypical, or unexplained fourth nerve palsy should undergo formal ophthalmic or neuro-ophthalmic evaluation.

Neurology may be appropriate when associated neurologic signs are present.

Surgical Treatment

Strabismus surgery may be considered when:

• Diplopia persists
• The deviation has become stable
• Prisms do not provide adequate relief
• A significant compensatory head posture remains

Surgery is usually deferred until spontaneous recovery is no longer expected.

For newly acquired palsies, this often means waiting many months, commonly close to a year depending on the etiology and clinical course.

Possible procedures include weakening or strengthening selected extraocular muscles based on the specific deviation pattern.

Ongoing Care

Patients should be monitored for:

• Improvement of diplopia
• Change in hypertropia
• Development of torsional symptoms
• Resolution of compensatory head posture
• Evidence of another neurologic process

Children with congenital palsy should also be assessed for:

• Amblyopia
• Strabismus
• Facial asymmetry from longstanding head tilt

Prognosis

Many patients with microvascular or traumatic fourth nerve palsy experience spontaneous improvement over several months.

Recovery may occur within approximately 3–9 months, although the exact course depends on the cause and severity of injury.

Congenital palsies generally do not recover anatomically but may remain well compensated for long periods.

High-Yield Clinical Pearl

Think of a fourth nerve palsy when a patient has vertical or diagonal diplopia that is worse on downgaze, a hypertropia that increases with head tilt toward the affected side, and a compensatory head tilt away from the palsied side.

Ophthalmology – Isolated Oculomotor Nerve (Cranial Nerve III) Palsy

Basics

Description

The oculomotor nerve, or cranial nerve III, innervates most of the extraocular muscles as well as the levator muscle of the upper eyelid and the parasympathetic fibers controlling pupillary constriction.

It supplies the:

• Levator palpebrae superioris
• Superior rectus
• Medial rectus
• Inferior rectus
• Inferior oblique
• Pupillary constrictor pathway through parasympathetic fibers

A complete third nerve palsy therefore causes a combination of ptosis, ophthalmoplegia, and sometimes pupillary dilation.

Pupillary involvement in a third nerve palsy represents an efferent pupillary abnormality, not a relative afferent pupillary defect.

Alert

A nontraumatic third nerve palsy with ipsilateral pupillary dilation must be considered compressive until proven otherwise.

The most important life-threatening cause is a posterior communicating artery aneurysm.

This requires urgent vascular imaging and neurologic or neurosurgical assessment.

Anatomy and Pathophysiology

The third nerve emerges from the midbrain and travels through the subarachnoid space near the posterior communicating artery before entering the cavernous sinus and orbit.

The parasympathetic pupillary fibers lie relatively superficially along the outside of the nerve.

Because of this arrangement, an external compressive lesion such as an aneurysm can preferentially affect these superficial fibers and produce:

• A dilated pupil
• Poor or absent pupillary light response

By contrast, microvascular ischemic lesions related to diabetes or hypertension tend to affect the deeper central portion of the nerve and may initially spare the superficial pupillary fibers.

This is the basis of the traditional distinction between pupil-involving and pupil-sparing third nerve palsies, although modern evaluation relies heavily on imaging rather than the pupil alone.

Etiology

Important causes include:

• Microvascular ischemia
• Posterior communicating artery aneurysm
• Trauma
• Tumor
• Infiltrative disease
• Inflammation
• Vasculitis
• Infection
• Cavernous sinus disease
• Midbrain lesions

Microvascular palsies are commonly associated with:

• Diabetes mellitus
• Hypertension
• Hyperlipidemia
• Other vascular risk factors

Pediatric Considerations

Third nerve palsy is uncommon in children.

Possible causes include:

• Congenital palsy
• Birth trauma
• Head trauma
• Tumor
• Infection
• Inflammatory disease
• Ophthalmoplegic neuropathy

Aneurysmal third nerve palsy is much less common in children than in adults.

Children, particularly those within the amblyogenic age range, must be monitored closely for amblyopia.

Severe ptosis or persistent ocular misalignment can interfere with visual development.

Pregnancy Considerations

Third nerve palsy is unusual in pregnancy.

Important causes to consider include:

• Pituitary apoplexy
• Gestational diabetes
• Hypertension
• Vascular disease

Pregnant patients with a new neurologic ocular motor deficit require appropriate urgent evaluation.

Diagnosis

History

Patients often complain of binocular diplopia.

The images are commonly separated:

• Horizontally
• Vertically
• Diagonally

Diplopia disappears when either eye is covered.

However, a patient with complete third nerve palsy and severe ptosis may not complain of diplopia because the drooping eyelid occludes the affected eye.

Important historical questions include:

• Sudden versus gradual onset
• Headache
• Periorbital pain
• Trauma
• Diabetes
• Hypertension
• Cancer history
• Inflammatory disease
• Symptoms of giant cell arteritis in older adults
• Other neurologic symptoms

Physical Examination

Complete Third Nerve Palsy

A complete third nerve palsy classically produces:

• Ptosis
• Eye positioned down and out
• Weakness of adduction
• Weakness of elevation
• Weakness of depression
• Possible pupillary dilation

The eye assumes a down-and-out position because the intact lateral rectus and superior oblique remain relatively unopposed.

Ptosis

Ptosis results from weakness of the levator palpebrae superioris.

It may be partial or complete.

Complete ptosis can mask the ocular deviation and may initially reduce the patient’s awareness of diplopia.

Ocular Motility

Because cranial nerve III controls most extraocular muscles, the affected eye typically has impaired:

• Adduction
• Elevation
• Depression

Abduction remains intact because it is controlled by cranial nerve VI.

Intorsion from the superior oblique, supplied by cranial nerve IV, should also be assessed.

Pupil-Sparing Third Nerve Palsy

A truly pupil-sparing third nerve palsy has:

• Normal pupillary size and reactivity
• Significant or complete weakness of third nerve-mediated eye movements
• Ptosis

Traditionally, this pattern suggests a microvascular ischemic mechanism, particularly in an older patient with diabetes or hypertension.

However, pupillary sparing alone should not be considered an absolute guarantee against a compressive lesion.

Pupil-Involving Third Nerve Palsy

A pupil-involving palsy demonstrates:

• Ipsilateral mydriasis
• Poor pupillary constriction
• Third nerve ophthalmoplegia

This pattern is especially concerning for compressive aneurysm, particularly when the onset is acute and accompanied by pain or headache.

Urgent vascular imaging is required.

Aberrant Regeneration

Damaged third nerve fibers may regenerate along abnormal pathways, producing oculomotor synkinesis.

A classic example is lid-gaze synkinesis, in which a ptotic eyelid elevates when the patient:

• Adducts the eye
• Looks downward

Another finding is pupil-gaze synkinesis, in which the pupil constricts abnormally during adduction.

Primary Aberrant Regeneration

Primary aberrant regeneration occurs without a previously documented acute third nerve palsy.

This pattern suggests a chronic compressive lesion, especially within the:

• Cavernous sinus
• Parasellar region

Possible causes include:

• Meningioma
• Aneurysm
• Other slowly growing compressive lesions

Secondary Aberrant Regeneration

Secondary aberrant regeneration occurs during recovery from a known third nerve injury.

It is particularly associated with:

• Trauma
• Compression

It is unusual following a straightforward microvascular ischemic palsy.

Diagnostic Tests and Interpretation

Blood Testing

If diabetes is suspected, appropriate testing includes:

• Blood glucose
• HbA1c

Additional vascular evaluation may include serum lipid testing.

In older patients with symptoms suggestive of giant cell arteritis, obtain inflammatory markers such as:

• ESR
• CRP

Other testing depends on the clinical scenario.

Imaging

Modern evaluation of a new third nerve palsy generally has a low threshold for neurovascular imaging.

Pupil-Involving Third Nerve Palsy

Urgent imaging is required to exclude aneurysm.

Appropriate studies include:

• CT angiography
• MR angiography

MRI of the brain and orbits may also be useful depending on the clinical presentation.

If noninvasive imaging remains inconclusive but clinical suspicion for aneurysm remains high, further vascular assessment may be required.

Persistent Palsy

If a presumed microvascular palsy does not begin to improve within the expected period or remains significantly abnormal after several months, further imaging should be considered.

MRI is useful for excluding:

• Mass lesions
• Infiltrative disease
• Cavernous sinus disease
• Midbrain pathology

Lumbar Puncture

Lumbar puncture may be considered when:

• Imaging is unrevealing
• Infection or inflammation is suspected
• Meningeal disease remains in the differential diagnosis

It is not routinely required for a typical isolated microvascular palsy.

Differential Diagnosis

Myasthenia Gravis

Myasthenia can closely mimic a pupil-sparing partial third nerve palsy.

Features favoring myasthenia include:

• Fluctuating weakness
• Fatigability
• Variable ptosis
• Changing ocular motility pattern
• Normal pupils

An isolated apparent medial rectus weakness should particularly raise concern for alternatives such as:

• Internuclear ophthalmoplegia
• Myasthenia gravis

rather than automatically being labeled a partial third nerve palsy.

Cavernous Sinus Lesion

A cavernous sinus process may affect multiple cranial nerves.

Examine carefully for:

• CN IV dysfunction
• CN VI dysfunction
• Reduced sensation in V1
• Reduced sensation in V2

Multiple cranial neuropathies strongly suggest a cavernous sinus or orbital apex process.

Giant Cell Arteritis

In older adults, giant cell arteritis can occasionally produce ocular motor nerve palsies.

Ask about:

• New headache
• Scalp tenderness
• Jaw claudication
• Weight loss
• Polymyalgia symptoms

Because untreated GCA can cause bilateral irreversible blindness, suspected cases require immediate treatment and systemic evaluation.

Adie Tonic Pupil

If the patient has an isolated dilated pupil but:

• Normal eyelid function
• Normal ocular motility
• No other third nerve findings

then a complete third nerve palsy is unlikely.

A tonic pupil, pharmacologic dilation, or local iris abnormality should be considered.

Treatment

Treatment depends on the underlying cause.

Aneurysmal Third Nerve Palsy

A suspected aneurysmal palsy requires urgent:

• Neurovascular imaging
• Neurology or neurosurgical consultation

Definitive treatment may involve:

• Endovascular coiling
• Surgical clipping
• Other vascular intervention

depending on aneurysm anatomy and clinical circumstances.

Microvascular Third Nerve Palsy

Management focuses on vascular risk-factor control.

Important measures include optimization of:

• Blood pressure
• Blood glucose
• Lipid levels
• Smoking status
• Overall cardiovascular risk

Most isolated microvascular third nerve palsies improve spontaneously.

Giant Cell Arteritis

When GCA is strongly suspected, treatment should begin immediately rather than waiting for definitive confirmation.

High-dose corticosteroid therapy is required, with route determined by visual and systemic findings.

Diplopia Management

Temporary symptomatic options include:

• Occlusion of one eye
• Frosting one spectacle lens
• Temporary patching

Prisms are often of limited benefit early because the deviation is usually highly incomitant, meaning it changes substantially with gaze direction.

Children and Amblyopia

Children in the amblyogenic age range require close monitoring.

Management may include:

• Patching
• Optical correction
• Treatment of strabismic amblyopia
• Management of visual-axis obstruction from ptosis

The goal is to preserve visual development while the neurologic disorder is being treated or observed.

Referral

Urgent neurology or neurosurgical assessment is indicated for:

• Pupil-involving third nerve palsy
• Suspected aneurysm
• Progressive neurologic findings
• Severe headache
• Additional cranial neuropathies

Other referrals may include:

• Primary care
• Endocrinology
• Rheumatology
• Neuro-ophthalmology

depending on the underlying cause.

Follow-Up

A new presumed microvascular pupil-sparing third nerve palsy requires close early observation.

The pupil and ocular motility should be rechecked to ensure that:

• Pupillary involvement does not develop
• No additional neurologic signs appear
• The palsy begins to improve as expected

Historically, daily or very frequent pupil reassessment during the first several days was recommended when immediate imaging was not performed.

Prognosis

The prognosis depends strongly on the etiology.

Microvascular ischemic palsies often show substantial spontaneous improvement over several weeks to months.

Compressive, traumatic, or infiltrative lesions may have incomplete recovery.

Persistent Strabismus

If significant ocular misalignment remains stable long after neurologic recovery, strabismus surgery may be considered.

Surgical rehabilitation is generally more successful in a partial third nerve palsy than in a complete palsy.

Ptosis Surgery

Persistent ptosis may eventually be treated surgically.

However, caution is necessary in patients with:

• Poor Bell phenomenon
• Significant ophthalmoplegia
• Reduced corneal sensation

because lifting the eyelid can produce serious exposure keratopathy.

In severe complete palsy, frontalis suspension or other reconstructive procedures may provide cosmetic and functional improvement, but normal ocular motility is unlikely to be restored.

Complications

The most important complication is failure to recognize a posterior communicating artery aneurysm, which can be life-threatening.

Other complications include:

• Persistent diplopia
• Chronic strabismus
• Persistent ptosis
• Aberrant regeneration
• Exposure keratopathy after ptosis repair
• Amblyopia in children
• Permanent neurologic deficits

Unrecognized giant cell arteritis can result in catastrophic bilateral visual loss.

The key clinical principle is: an acute third nerve palsy with pupillary involvement requires urgent exclusion of a compressive aneurysm, while an apparently microvascular palsy still requires careful clinical assessment and follow-up.

Ophthalmology – Iritis-Uveitis in Children

Basics

Description

Uveitis refers to intraocular inflammation. In children, it can involve different parts of the eye and may be classified anatomically.

Anterior uveitis involves the iris and ciliary body and includes iritis and iridocyclitis. Intermediate uveitis mainly involves the pars plana and vitreous, as in pars planitis. Posterior uveitis involves the retina and/or choroid and may also affect the optic nerve and vitreous. Panuveitis refers to inflammation involving multiple segments of the eye.

Childhood uveitis is less common than adult uveitis but may be particularly dangerous because some forms are asymptomatic despite active inflammation.

Epidemiology

Childhood uveitis is uncommon.

Reported incidence is approximately 4–7 cases per 100,000 children, with prevalence around 30 per 100,000.

A large proportion of cases are idiopathic, but juvenile idiopathic arthritis (JIA) is the most important systemic association with noninfectious anterior uveitis in children.

Risk Factors

Important risk factors include:

• Juvenile idiopathic arthritis
• Autoimmune disease
• HLA-B27-associated disease
• Congenital or acquired infections
• Ocular trauma
• Immunosuppression
• Exposure to infectious agents

JIA-Related Risk Factors

Children at particularly high risk for JIA-associated uveitis include those with:

• Oligoarticular JIA
• Young age at arthritis onset
• Positive ANA
• Negative rheumatoid factor
• Female sex

The ocular inflammation may occur independently of joint activity.

Genetics

Genetic predisposition contributes to several causes of childhood uveitis.

HLA-B27 is associated with acute anterior uveitis and with systemic disorders such as:

• Ankylosing spondylitis
• Reactive arthritis
• Psoriatic arthritis
• Inflammatory bowel disease-associated arthritis

Genetic susceptibility often interacts with environmental or infectious triggers.

General Prevention

The most important preventive measure is regular ophthalmologic screening of children at risk, especially those with JIA.

Because JIA-associated uveitis may occur in a completely white, quiet, asymptomatic eye, relying on symptoms can lead to delayed diagnosis and irreversible complications.

Prevention also includes appropriate treatment of systemic disease and avoidance or early treatment of infections when possible.

Pathophysiology

The mechanism depends on the underlying cause.

In autoimmune disease, inflammation is thought to result from dysregulated immune responses directed against ocular tissues.

The exact mechanism of JIA-associated uveitis remains incompletely understood.

Chronic inflammation can damage:

• Cornea
• Iris
• Trabecular meshwork
• Lens
• Vitreous
• Retina
• Optic nerve

This explains the broad range of potential complications.

Etiology

Anterior Uveitis

Important causes include:

• Juvenile idiopathic arthritis
• Idiopathic anterior uveitis
• HLA-B27-associated disease
• Trauma
• Behçet disease
• Sarcoidosis
• Kawasaki disease
• Tubulointerstitial nephritis and uveitis syndrome
• HSV or VZV
• Syphilis
• Tuberculosis
• Lyme disease
• Toxoplasmosis and other infections

Masquerade syndromes must also be considered, including:

• Retinoblastoma
• Leukemia
• Lymphoma
• Juvenile xanthogranuloma
• Coats disease
• Intraocular foreign body

JIA-Associated Uveitis

JIA is the most important cause of chronic noninfectious anterior uveitis in children.

The highest risk occurs with oligoarticular JIA.

The ocular disease may:

• Precede arthritis
• Occur during active arthritis
• Continue when joint disease is inactive

There is often no relationship between joint symptoms and ocular inflammatory activity.

The eye can appear externally normal despite significant inflammation.

A substantial proportion of affected children require prolonged treatment.

HLA-B27-Associated Uveitis

Children with enthesitis-related arthritis may develop HLA-B27-associated anterior uveitis.

Unlike classic JIA-associated uveitis, this form is more likely to be:

• Symptomatic
• Acute
• Painful
• Red
• Photophobic

Intermediate Uveitis

Possible causes include:

• Idiopathic intermediate uveitis
• Pars planitis
• Sarcoidosis
• Inflammatory bowel disease
• Multiple sclerosis
• Lyme disease

Intermediate uveitis is relatively uncommon in JIA.

Posterior Uveitis

Infectious causes are particularly important.

Toxoplasmosis is one of the most common infectious causes of posterior uveitis in children.

Other causes include:

• Toxocariasis
• Tuberculosis
• Syphilis
• Lyme disease
• Bartonella
• Fungal infection
• Bacterial infection
• HSV
• VZV
• CMV

Noninfectious causes include:

• Sarcoidosis
• Vogt-Koyanagi-Harada disease
• Sympathetic ophthalmia
• Masquerade syndromes

Panuveitis

Panuveitis may be caused by:

• Infection
• Systemic inflammatory disease
• Autoimmune disorders
• Masquerade syndromes

Because multiple ocular compartments are involved, extensive systemic evaluation may be necessary.

Commonly Associated Ocular Conditions

Childhood uveitis can be associated with:

• Band keratopathy
• Cataract
• Posterior synechiae
• Peripheral anterior synechiae
• Glaucoma
• Cystoid macular edema
• Chorioretinal scarring
• Retinal detachment
• Hypotony
• Vitreous hemorrhage
• Permanent vision loss

Diagnosis

History

History may provide the most important clues to the underlying cause.

Ask about:

• Eye redness
• Pain
• Photophobia
• Floaters
• Blurred vision
• Reduced vision
• Joint pain or swelling
• Skin rash
• Oral ulcers
• Fever
• Weight loss
• Recent infections
• Exposure to tuberculosis
• Tick exposure
• Travel
• Trauma
• Family history of autoimmune disease

Importantly, absence of ocular symptoms does not exclude active uveitis, particularly in JIA.

Physical Examination

A complete pediatric and ophthalmic examination should be performed.

Visual Acuity

Age-appropriate visual acuity testing is essential.

Young children may require:

• Fixation assessment
• Picture-based testing
• Matching symbols

Amblyopia may coexist and complicate interpretation.

Intraocular Pressure

IOP may be:

• Low during active ciliary body inflammation
• Elevated from chronic inflammation
• Elevated from steroid response
• Elevated from angle damage or synechiae

Both the disease and its treatment can therefore cause glaucoma.

Conjunctiva and Sclera

Possible findings include:

• Ciliary flush
• Episcleritis
• Scleritis
• Conjunctival nodules

The eye may nevertheless appear completely quiet in chronic JIA-associated uveitis.

Cornea

Possible findings include:

• Corneal edema
• Keratic precipitates
• Band keratopathy
• Interstitial keratitis
• Dendritic or geographic epithelial lesions in herpetic disease

Keratic precipitates may be small and nongranulomatous or larger and greasy in appearance, termed mutton-fat KPs.

Anterior Chamber

Slit-lamp examination may reveal:

• Cells
• Flare
• Fibrin
• Hypopyon

Anterior chamber cells are graded according to the number seen in a standardized slit beam.

Flare represents leakage of protein into the aqueous because of breakdown of the blood-aqueous barrier.

A true hypopyon contains inflammatory white blood cells. A pseudohypopyon can occur with tumor cells and should raise concern for a masquerade syndrome.

Iris

Important findings include:

• Posterior synechiae
• Peripheral anterior synechiae
• Iris nodules
• Iris neovascularization
• Irregular pupil

Posterior synechiae occur when the iris adheres to the anterior lens capsule.

Lens

Chronic inflammation and corticosteroid treatment may both lead to cataract formation.

Gonioscopy

Gonioscopy can identify:

• Peripheral anterior synechiae
• Angle closure
• Neovascularization
• Inflammatory debris

It is particularly important in children with elevated IOP.

Vitreous

The vitreous may contain:

• Inflammatory cells
• Haze
• Hemorrhage
• Membranes

These findings indicate intermediate or posterior segment involvement.

Retina

Possible retinal findings include:

• Cystoid macular edema
• Cotton-wool spots
• Retinal hemorrhages
• Vascular sheathing
• Neovascularization
• Retinal detachment

Choroid

Choroidal inflammatory lesions may occur in systemic inflammatory and infectious disease.

Certain inflammatory disorders may produce small yellow-white lesions at the level of the retinal pigment epithelium and choroid.

Pars Plana

Intermediate uveitis may produce:

• Snowballs
• Snowbanking
• Peripheral neovascularization

Snowbanking refers to white inflammatory exudates over the pars plana.

Optic Nerve

Possible findings include:

• Optic disc edema
• Optic atrophy
• Neovascularization
• Infiltration

Optic nerve involvement may substantially worsen the visual prognosis.

Diagnostic Tests and Interpretation

The workup should be directed by the history and examination, rather than using a broad laboratory panel in every child.

Laboratory Testing

Possible tests include:

• CBC with differential
• ESR and/or CRP
• ANA
• ACE
• Serum calcium
• Syphilis serology
• Tuberculosis testing
• Lyme serology when epidemiologically appropriate
• HLA-B27 when clinically indicated
• Urinalysis

Additional targeted studies may be appropriate based on the suspected diagnosis.

Urinalysis and TINU

Urinalysis can be particularly useful when tubulointerstitial nephritis and uveitis syndrome is suspected.

Renal abnormalities may precede, accompany, or follow the ocular disease.

Chest Imaging

Chest radiography may be considered when evaluating for:

• Sarcoidosis
• Tuberculosis

Further chest imaging may be needed when suspicion remains high.

Ocular Ultrasound

B-scan ultrasonography can be useful when media opacity prevents adequate visualization of the posterior segment.

It can identify:

• Retinal detachment
• Vitreous abnormalities
• Mass lesions

OCT

Optical coherence tomography is especially useful for detecting and monitoring:

• Cystoid macular edema
• Epiretinal membrane
• Structural macular damage

Fluorescein Angiography

Fluorescein angiography may demonstrate:

• Retinal vasculitis
• Macular edema
• Capillary leakage
• Neovascularization

Wide-field angiography may be particularly useful for detecting peripheral inflammation.

Other Investigations

Depending on the clinical context, additional evaluation may include:

• MRI of brain or orbits
• Sacroiliac or hand imaging
• Lumbar puncture
• ANCA
• HIV testing
• Stool testing for parasites
• Skin testing for tuberculosis
• ERG
• VEP
• Visual fields
• Aqueous or vitreous sampling
• Tissue biopsy

Differential Diagnosis

Important masquerade and alternative diagnoses include:

• Retinoblastoma
• Leukemia
• Lymphoma
• Trauma
• Retained intraocular foreign body
• Coats disease
• Juvenile xanthogranuloma
• Retinal dystrophies
• Infectious retinitis

Atypical inflammation, poor response to therapy, or pseudohypopyon should increase concern for a masquerade syndrome.

Treatment

Treatment depends on:

• Anatomic location
• Severity
• Underlying cause
• Presence of infection
• Risk of complications

The major goals are to suppress inflammation, prevent structural damage, treat the cause, and preserve visual development.

Topical Corticosteroids

Topical corticosteroids are first-line therapy for many forms of anterior noninfectious uveitis.

Frequency depends on severity and may range from several times daily to very frequent dosing in severe disease.

Treatment must be tapered according to clinical response.

Prolonged corticosteroid use can cause:

• Cataract
• Ocular hypertension
• Glaucoma

Cycloplegic Therapy

Cycloplegics are used to:

• Relieve pain from ciliary spasm
• Reduce photophobia
• Prevent or break posterior synechiae

The specific agent and frequency depend on the degree of inflammation.

Periocular Corticosteroids

Periocular steroid injections may be considered when:

• Topical treatment is insufficient
• Intermediate or posterior inflammation is present
• Macular edema is significant

Potential complications must be considered carefully in children.

Systemic Corticosteroids

Systemic corticosteroids may be required for:

• Severe bilateral disease
• Posterior uveitis
• Panuveitis
• Sight-threatening inflammation
• Disease inadequately controlled with local therapy

Long-term systemic corticosteroid exposure is undesirable in children because of effects on:

• Growth
• Bone health
• Metabolism
• Immune function

Therefore, steroid-sparing therapy should be considered early when chronic treatment is expected.

Immunomodulatory Therapy

Systemic immunomodulatory therapy should be managed by physicians experienced with these medications, usually in collaboration with pediatric rheumatology.

Methotrexate

Methotrexate is a common first-line steroid-sparing agent for chronic JIA-associated uveitis when topical therapy is inadequate or prolonged steroid exposure would be required.

Biologic Therapy

Biologic agents, particularly anti-TNF therapy, may be used for refractory disease.

Adalimumab is an important treatment for JIA-associated uveitis when conventional immunomodulation is inadequate.

Other agents may be considered in selected cases.

Additional Immunosuppressive Agents

Options may include:

• Mycophenolate mofetil
• Azathioprine
• Cyclosporine
• Tacrolimus
• Rituximab in selected refractory cases
• Alkylating agents for severe resistant disease

Therapy is individualized according to diagnosis and response.

Infectious Uveitis

Infectious causes require specific antimicrobial treatment.

Corticosteroids should not be used as stand-alone therapy when active infection is present.

Depending on the infection, treatment may involve:

• Antivirals
• Antibiotics
• Antituberculous therapy
• Antiparasitic medication
• Antifungal therapy

Infectious disease consultation may be appropriate.

Referral

Children without an obvious isolated traumatic cause generally benefit from multidisciplinary evaluation.

Referral may include:

• Pediatric rheumatology
• Infectious disease
• Oncology
• Neurology
• Nephrology
• Genetics

depending on the suspected etiology.

Surgical Treatment

Band Keratopathy

Visually significant band keratopathy may be treated with EDTA chelation after inflammation is adequately controlled.

Cataract Surgery

Cataract surgery may be required when lens opacity significantly limits vision.

Ideally, inflammation should be well controlled before surgery.

These children are at increased risk for:

• Postoperative inflammation
• Posterior synechiae
• Glaucoma
• Posterior capsule opacification

Glaucoma Surgery

Glaucoma that cannot be controlled medically may require surgery.

Retinal Procedures

Retinal laser or retinal detachment repair may be necessary for posterior segment complications.

Drug-Delivery Implants

Local sustained-release drug-delivery systems may be considered in carefully selected refractory cases.

Inpatient Considerations

Most childhood uveitis is managed as an outpatient.

Hospital admission may be required when:

• Severe systemic disease is present
• Intravenous antimicrobial therapy is needed
• High-dose intravenous corticosteroids are required
• A serious masquerade or systemic inflammatory disorder is being evaluated

Ongoing Care

Follow-Up

Children require frequent ophthalmologic examinations, particularly when inflammation is active.

Follow-up should monitor:

• Visual acuity
• Amblyopia
• Anterior chamber cells and flare
• IOP
• Cataract
• Synechiae
• Band keratopathy
• Macular edema
• Retinal disease
• Medication toxicity

Systemic Monitoring

Children receiving systemic immunosuppression require regular monitoring appropriate to the medication.

Because children grow, weight-based drug doses must be reassessed periodically.

Coordination among ophthalmology, rheumatology, primary care, and other specialists is essential.

Amblyopia

Amblyopia deserves special attention in pediatric uveitis.

Vision may be reduced not only by inflammation but also by:

• Cataract
• Corneal opacity
• Refractive error
• Strabismus

These factors can interfere with visual development even after the inflammation has been controlled.

Patient and Family Education

Parents should understand that:

• Uveitis may be present without symptoms
• Regular eye examinations are essential
• Treatment may need to continue for years
• Medications must not be stopped abruptly without medical advice
• Glaucoma and cataract can result from both the disease and its treatment

Families should be encouraged to maintain close follow-up even when the child’s eyes appear normal.

Prognosis

Early recognition and aggressive control of inflammation can substantially reduce the risk of permanent visual loss.

Prognosis depends on:

• Underlying etiology
• Duration before diagnosis
• Location of inflammation
• Presence of complications
• Response to treatment
• Adherence to follow-up

Children with chronic asymptomatic anterior uveitis may already have complications at the time of diagnosis if screening has been inadequate.

Complications

Major complications include:

• Band keratopathy
• Cataract
• Posterior synechiae
• Secondary glaucoma
• Cystoid macular edema
• Hypotony
• Optic disc edema
• Vitreous hemorrhage
• Epiretinal or vitreoretinal membranes
• Retinal detachment
• Phthisis bulbi
• Amblyopia
• Permanent visual loss

The most important clinical pearl is that JIA-associated uveitis can be severe despite a completely white, painless eye, making scheduled slit-lamp screening essential for children at risk.

Ophthalmology – Iris Nevus

Basics

Description

An iris nevus is a benign melanocytic tumor arising from the iris stroma. Iris melanocytic lesions form a spectrum ranging from harmless freckles and nevi to malignant iris melanoma.

Iris nevi can vary considerably in:

• Size
• Shape
• Thickness
• Degree of pigmentation
• Circumscribed versus diffuse appearance

A key distinction is that an iris nevus distorts or replaces the normal iris stromal architecture, whereas an iris freckle is a superficial area of pigmentation that does not alter the underlying iris structure.

Iris freckles are extremely common and have essentially no malignant potential.

Iris nevi usually become clinically apparent during childhood, puberty, or young adulthood and often remain stable for many years.

Alert

A pigmented iris lesion showing documented progressive enlargement should raise concern for iris melanoma.

Other concerning features include:

• Secondary glaucoma
• Angle involvement
• Tumor seeding
• Prominent intrinsic vessels
• Hyphema
• Increasing thickness

Special Variant – Iris Melanocytoma

Iris melanocytoma is a deeply pigmented variant of melanocytic nevus.

It is usually benign but may undergo spontaneous necrosis.

Necrotic tumor cells and pigment can disperse into the anterior chamber and obstruct the trabecular meshwork, producing secondary glaucoma. This is sometimes called melanocytomalytic glaucoma.

Melanocytoma may also have an associated ciliary body component.

Malignant transformation is possible but uncommon.

Pediatric Considerations

Iris nevi are often first detected during childhood, particularly in the preteen or adolescent years.

Most remain stable into adulthood.

Because many lesions are discovered incidentally, baseline photography is particularly valuable in children to allow accurate comparison over time.

Geriatric Considerations

An iris nevus discovered in an older patient may have been present for decades.

A newly noticed lesion in an older adult is not automatically malignant, but suspicious features or documented growth deserve careful evaluation.

Epidemiology

Iris freckles are very common and can be seen in approximately half or more of the general population.

True iris nevi are less common, occurring in roughly 5% of individuals.

Most are benign and remain stable.

Risk Factors

Reported associations include:

• White race
• Light iris color, particularly blue, gray, or green
• Inferior location of the lesion

Most iris nevi and many iris melanomas are located in the inferior half of the iris.

Sectoral iris nevi may be associated with ocular melanocytosis.

General Prevention

There is no proven method to prevent iris nevi.

Reasonable preventive measures include:

• Limiting excessive ultraviolet exposure
• Wearing UV-protective sunglasses
• Regular ophthalmic follow-up for suspicious lesions

The most important strategy is documenting a lesion early so that subsequent growth can be recognized.

Etiology

The exact cause is unknown.

Iris nevi arise from benign proliferation of melanocytes within the iris stroma.

Commonly Associated Conditions

Most iris nevi occur in otherwise normal eyes.

Some may be associated with:

• Sectoral ocular melanocytosis
• Iris pigment epithelial cysts
• Secondary cataract
• Rare secondary glaucoma

Diagnosis

History

Most patients are asymptomatic.

The lesion may be:

• Noticed by the patient
• Noticed by a family member
• Found incidentally during a routine ophthalmic examination

Important historical questions include:

• How long has the lesion been present?
• Has its size or color changed?
• Is there a previous photograph?
• Has there been pain, redness, or blurred vision?
• Has the patient ever been told the IOP is elevated?
• Is there a history of ocular melanoma or melanocytosis?

Documented stability strongly favors a benign nevus.

Physical Examination

Iris nevi have a broad range of appearances.

They may be:

• Small or large
• Flat or mildly elevated
• Dome-shaped
• Circumscribed or sectoral
• Pigmented or nonpigmented
• Uniform or heterogeneous in coloration

Possible secondary changes include:

• Corectopia
• Ectropion uveae
• Localized cataract
• Associated iris pigment epithelial cyst
• Intrinsic vascularity

Some benign nevi may have visible vessels, so vascularity alone does not establish malignancy.

Secondary Glaucoma

Glaucoma is uncommon with a simple iris nevus.

Therefore, elevated IOP in an eye with a melanocytic iris lesion should raise suspicion for:

• Iris melanoma
• Angle involvement
• Tumor seeding
• Melanocytoma with pigment dispersion

Unilateral unexplained glaucoma in association with an iris lesion warrants careful gonioscopy.

Sector Iris Nevus

A sector nevus extends radially from the pupillary margin toward the anterior chamber angle.

It may involve one or several clock hours.

Some authors consider this a localized manifestation of ocular melanocytosis.

Tapioca Nevus

A tapioca nevus has a multinodular surface composed of multiple small pale or pigmented elevations resembling tapioca pudding.

This appearance can resemble tapioca melanoma, so documentation of stability is particularly important.

Diffuse Iris Nevus and Cogan–Reese Syndrome

The term “diffuse iris nevus” has sometimes been used in connection with Cogan–Reese syndrome.

However, Cogan–Reese syndrome is part of iridocorneal endothelial syndrome and is not a true melanocytic nevus.

Diagnostic Tests and Interpretation

Slit-Lamp Examination

Slit-lamp examination evaluates:

• Pigmentation
• Thickness
• Surface architecture
• Intrinsic vessels
• Corectopia
• Ectropion uveae
• Hyphema
• Tumor seeding

Careful serial examinations are essential.

Anterior Segment Photography

Baseline photography is one of the most useful tools in managing an iris nevus.

Serial photographs allow detection of subtle:

• Growth
• Shape change
• Color change
• New vascularity
• Pupillary distortion

Documented enlargement is one of the strongest indicators of malignant transformation.

Intraocular Pressure

IOP should be measured at every evaluation.

New or progressive elevation should prompt investigation for angle involvement or malignant transformation.

Gonioscopy

Gonioscopy is used to assess:

• Extension into the anterior chamber angle
• Abnormal pigmentation of the trabecular meshwork
• Tumor seeding
• Associated angle mass

Angle involvement is an important feature distinguishing a suspicious lesion from an uncomplicated nevus.

Transillumination

Transillumination helps assess whether the apparent iris lesion extends posteriorly into the ciliary body.

This is particularly important for thicker or peripheral tumors.

Ultrasound Biomicroscopy

UBM is useful for:

• Measuring lesion thickness
• Determining posterior extent
• Detecting ciliary body involvement
• Distinguishing a solid nevus from a cystic lesion
• Providing a baseline for future comparison

It is especially useful for larger or more heavily pigmented lesions.

Anterior-Segment OCT

AS-OCT can image smaller, superficial iris lesions.

It is particularly helpful for lightly pigmented or nonpigmented lesions.

However, deeply pigmented or thick lesions may cause significant posterior shadowing, limiting assessment of their full depth.

Fine-Needle Aspiration Biopsy

FNAB is not needed for routine stable iris nevi.

It may be considered when:

• The diagnosis remains uncertain
• The lesion has suspicious features
• Differentiation from melanoma would alter management

Because low-grade melanoma can resemble a nevus cytologically, samples should be interpreted by an experienced ocular cytopathologist.

Pathological Findings

Iris nevi are usually composed predominantly of low-grade spindle melanocytic cells.

Some borderline lesions are difficult to distinguish histologically from low-grade melanoma.

For this reason, clinical behavior over time, especially documented growth, remains extremely important.

Differential Diagnosis

Important differential diagnoses include:

• Iris melanoma
• Iris melanocytoma
• Ocular melanocytosis
• Iris pigment epithelial cyst
• Adenoma of the iris pigment epithelium
• ICE syndrome
• Iris lymphoma
• Iris metastasis
• Iris granuloma
• Juvenile xanthogranuloma
• Retained anterior chamber foreign body

The most clinically important distinction is between iris nevus and iris melanoma.

Features Suggesting Melanoma Rather Than Nevus

Concern for melanoma increases with:

• Documented growth
• Increasing thickness
• Secondary glaucoma
• Angle involvement
• Tumor seeding
• Prominent intrinsic or feeder vessels
• Spontaneous hyphema
• Increasing pupillary distortion
• Progressive ectropion uveae

A stable lesion without these features is much more likely to remain benign.

Treatment

Medication

There is no medication required for an uncomplicated iris nevus.

Observation

Observation is the standard management.

Baseline assessment should ideally include:

• Slit-lamp examination
• Anterior segment photography
• IOP measurement
• Gonioscopy
• UBM when appropriate
• Transillumination
• AS-OCT in selected lesions

Follow-up is then used to establish whether the lesion remains stable.

Follow-Up Interval

A suspicious or newly documented lesion may initially be reassessed at approximately 6 months.

Once long-term stability is established, follow-up can often be extended to 6–12 month intervals, depending on its characteristics.

Higher-risk lesions require closer surveillance.

Documented Growth

If a melanocytic iris lesion shows unequivocal progressive growth, it should no longer be managed as a simple nevus.

The patient should be evaluated for iris melanoma and referred to an ocular oncologist when appropriate.

Management of Elevated IOP

Topical glaucoma medications may be used if IOP elevation occurs.

However, because secondary glaucoma is unusual with a benign nevus, the lesion must be reassessed carefully for malignant transformation or angle involvement.

Associated Hyphema

If inflammation or hyphema accompanies a lesion, cycloplegics and topical anti-inflammatory therapy may be used when appropriate.

The cause of the bleeding must still be investigated.

Surgery

Routine surgical excision is not indicated for a stable iris nevus.

Treatment is reserved for lesions that:

• Demonstrate documented growth
• Develop convincing malignant features
• Produce significant complications requiring intervention

Such lesions should be managed according to principles used for iris melanoma.

Ongoing Care

Follow-Up Recommendations

Patients should undergo periodic ophthalmic examinations.

Monitoring may include:

• Slit-lamp examination
• Anterior segment photography
• Gonioscopy
• IOP measurement
• UBM
• Transillumination
• AS-OCT when useful

The precise testing schedule depends on the lesion’s size, location, and level of suspicion.

Patient Education

Patients should understand that most iris nevi are benign and remain stable throughout life.

They should also understand why periodic monitoring is important.

They should return earlier than scheduled if they notice:

• Increase in size
• Change in pupil shape
• New pain
• Blurred vision
• Redness
• Visible bleeding in the eye

Avoiding excessive sun exposure and using UV-protective eyewear is reasonable.

Prognosis

The overall prognosis is excellent.

Most iris nevi remain stable and never become malignant.

A small proportion of suspicious or borderline lesions may enlarge over time and ultimately prove to be melanoma.

Therefore, the goal of management is not to remove every iris nevus, but to document stability and promptly identify the uncommon lesion that begins to grow.

Complications

Possible complications include:

• Secondary cataract
• Pupillary distortion
• Ectropion uveae
• Rare secondary glaucoma
• Pigment dispersion from melanocytoma
• Rare malignant transformation into iris melanoma

The most important clinical principle is: a stable iris nevus is usually benign, but documented progressive growth or secondary glaucoma should prompt evaluation for iris melanoma.

Ophthalmology – Iris Melanoma

Alert

Any pigmented iris lesion should be examined carefully for features suggesting malignancy, especially tumor seeding, secondary glaucoma, intrinsic tumor vessels, documented growth, and angle involvement.

These findings are much more concerning for iris melanoma than for a stable iris nevus.

Basics

Description

Iris melanoma is a malignant melanocytic tumor arising from the iris stroma. It is uncommon and accounts for only a small proportion of all uveal melanomas.

The tumor may be pigmented or nonpigmented and can vary considerably in size, shape, and appearance.

Important clinical forms include:

• Circumscribed iris melanoma
• Diffuse iris melanoma
• Tapioca melanoma
• Trabecular meshwork melanoma

Iris melanoma may cause:

• Corectopia
• Ectropion uveae
• Secondary glaucoma
• Spontaneous hyphema
• Anterior chamber inflammation
• Tumor seeding onto the iris or angle

More than 80% of iris melanomas arise in the inferior half of the iris.

Although iris melanoma generally has a lower metastatic risk than choroidal melanoma, it can metastasize, particularly to the liver, and less commonly to other organs.

Pediatric Considerations

Iris melanoma is rare in children and young adults, but among younger patients who do develop uveal melanoma, the iris represents a relatively larger proportion of cases than it does in older adults.

Epidemiology

Iris melanoma represents approximately 4–5% of uveal melanomas.

Uveal melanoma itself is uncommon, with an incidence of only several cases per million population per year.

Secondary elevation of intraocular pressure is relatively common in established iris melanoma and may occur because of:

• Direct tumor invasion of the angle
• Tumor seeding
• Pigment or tumor-cell obstruction of aqueous outflow

Risk Factors

Important associations include:

• White race
• Light-colored iris
• Inferior iris location
• Ocular melanocytosis
• Preexisting suspicious iris nevus

Features that increase concern for malignant transformation of a nevus include:

• Documented enlargement
• Pigment dispersion onto adjacent iris
• Angle involvement
• Secondary glaucoma
• Intrinsic vessels
• Tumor seeding

Genetics

Iris melanomas may demonstrate chromosomal abnormalities involving chromosomes 3, 6, and 8.

As with other uveal melanomas, certain cytogenetic features are associated with different metastatic risks.

Monosomy 3 is generally considered a higher-risk feature, whereas disomy 3 is associated with a lower metastatic risk.

Fine-needle aspiration biopsy may be used in selected cases for cytologic or molecular analysis.

General Prevention

There is no proven method to prevent iris melanoma.

Reasonable measures include:

• Limiting excessive ultraviolet exposure
• Wearing UV-protective eyewear
• Regular ophthalmic monitoring of suspicious iris lesions

The most important preventive strategy is early recognition of malignant transformation in a previously observed iris lesion.

Pathophysiology

Iris melanoma develops from malignant transformation of melanocytes within the iris stroma.

The tumor may remain localized or spread:

• Across the iris surface
• Into the anterior chamber angle
• Into the trabecular meshwork
• Into the ciliary body
• Extraocularly in advanced disease

Tumor cells may shed into the anterior chamber and produce visible seeding on the iris or angle.

Angle infiltration and seeding can obstruct aqueous outflow and produce secondary glaucoma.

Etiology

The exact cause is unknown.

Genetic susceptibility, melanocytic abnormalities, and environmental factors may contribute, but no single cause has been established.

Clinical Types

Circumscribed Iris Melanoma

This is the most common presentation.

It appears as a relatively well-defined mass within the iris stroma.

Features may include:

• Nodular or dome-shaped configuration
• Variable pigmentation
• Distortion of the pupil
• Intrinsic vessels
• Ectropion uveae
• Local angle involvement

Localized lesions without extensive seeding may be amenable to surgical excision.

Diffuse Iris Melanoma

Diffuse melanoma spreads across a broad portion of the iris rather than forming a single discrete mass.

It may produce:

• Acquired hyperchromic heterochromia
• Diffuse iris thickening
• Loss of normal iris architecture
• Progressive secondary glaucoma
• Extensive angle infiltration

Because the tumor may be subtle, the diagnosis can be delayed.

Tapioca Melanoma

This rare form has multiple small translucent or lightly pigmented nodules scattered over the iris surface.

The appearance has been compared with tapioca pudding.

It may be mistaken for inflammatory or benign nodular iris disease.

Trabecular Meshwork Melanoma

This form primarily involves the anterior chamber angle and trabecular meshwork without an obvious iris mass.

Patients may initially present with unilateral secondary glaucoma.

It can be mistaken for:

• Pigmentary glaucoma
• Other secondary glaucomas

Unexplained unilateral glaucoma with abnormal angle pigmentation should therefore prompt careful gonioscopic examination.

Diagnosis

History

Patients may be asymptomatic, with the lesion found during routine examination.

Possible symptoms include:

• Visible iris spot or mass
• Change in iris color
• Distorted pupil
• Blurred vision
• Eye pain
• Redness
• Symptoms of elevated IOP

Pain and visual loss often occur when secondary glaucoma develops.

A history of a previously documented iris nevus is particularly useful because growth over time is one of the strongest signs of malignancy.

Physical Examination

A complete ophthalmic examination should include:

• Visual acuity
• IOP measurement
• Slit-lamp examination
• Gonioscopy
• Transillumination
• Dilated examination

Concerning features include:

• Documented tumor growth
• Intrinsic tumor vessels
• Feeder vessels
• Corectopia
• Ectropion uveae
• Tumor seeding
• Secondary glaucoma
• Hyphema
• Angle invasion

Secondary Glaucoma

Elevated IOP is an important warning sign.

Glaucoma is unusual in a simple iris nevus, so unilateral glaucoma associated with an iris lesion should raise suspicion for melanoma.

Possible mechanisms include:

• Direct angle invasion
• Trabecular obstruction by tumor cells
• Tumor seeding
• Pigment dispersion
• Neovascular mechanisms in advanced disease

Tumor Seeding

Tumor cells may appear as fine pigmented or nonpigmented deposits on:

• The iris surface
• The anterior chamber angle
• Other anterior segment structures

Seeding is best identified with careful slit-lamp examination and gonioscopy.

Its presence strongly supports malignant behavior.

Diagnostic Tests and Interpretation

Anterior Segment Photography

Serial slit-lamp photographs are extremely useful.

They document:

• Tumor size
• Pigmentation
• Vascularity
• Pupillary distortion
• Growth over time

Documented enlargement is one of the most important criteria for treatment.

Ultrasound Biomicroscopy

UBM is very useful for evaluating iris melanoma.

It can:

• Measure tumor thickness
• Determine posterior extension
• Detect ciliary body involvement
• Distinguish solid tumors from cysts
• Assess angle involvement

Anterior-Segment OCT

AS-OCT may be useful for smaller, superficial, particularly nonpigmented iris lesions.

Its limitation is posterior shadowing, especially with larger or heavily pigmented tumors.

Gonioscopy

Gonioscopy is essential to determine:

• Angle involvement
• Trabecular pigmentation
• Tumor seeding
• Extent in clock hours

This information can significantly alter treatment planning and prognosis.

Transillumination

Transillumination may help determine whether the lesion extends posteriorly into the ciliary body.

Fine-Needle Aspiration Biopsy

FNAB may be useful when the diagnosis remains uncertain.

It can provide material for:

• Cytology
• Cytogenetic analysis
• Molecular prognostic testing

Interpretation should ideally be performed by an experienced ocular pathologist because low-grade melanomas may be difficult to distinguish from nevi histologically.

Systemic Evaluation

Because iris melanoma can metastasize, patients require systemic assessment.

The liver is the most important metastatic site in uveal melanoma.

Systemic surveillance is usually coordinated with ocular oncology and medical oncology and may include:

• Physical examination
• Liver function testing
• Liver imaging
• Other imaging based on risk and institutional protocol

Modern surveillance schedules vary according to tumor biology and metastatic risk.

Differential Diagnosis

Important mimics include:

• Iris nevus
• Iris melanocytoma
• Iris pigment epithelial cyst
• Adenoma of the iris pigment epithelium
• ICE syndrome
• Iris lymphoma
• Iris metastasis
• Iris granuloma
• Juvenile xanthogranuloma
• Retained anterior chamber foreign body
• Inflammatory iris nodules

The most important distinction is usually between iris nevus and iris melanoma.

Nevus Versus Melanoma

Features favoring melanoma include:

• Documented growth
• Larger size
• Greater thickness
• Intrinsic vascularity
• Ectropion uveae
• Corectopia
• Tumor seeding
• Angle involvement
• Secondary glaucoma
• Spontaneous hyphema

A stable, small lesion without these features is more likely to be benign.

Treatment

There is no established systemic medication that eradicates a localized primary iris melanoma.

Treatment is primarily local and depends on:

• Tumor size
• Location
• Circumscribed versus diffuse configuration
• Angle involvement
• Seeding
• Secondary glaucoma
• Visual potential

Observation

Small indeterminate lesions without clear malignant features may be observed closely.

Serial examination should include:

• Slit-lamp photography
• UBM
• Gonioscopy
• IOP measurement

Documented growth generally warrants treatment.

Surgical Excision

Localized circumscribed melanoma may be treated with surgical excision.

Procedures include:

• Iridectomy
• Iridocyclectomy
• Iridogoniocyclectomy

The choice depends on whether the tumor extends into:

• The angle
• Ciliary body
• Adjacent structures

Excision is most appropriate when the tumor is sufficiently localized and there is no extensive seeding.

Plaque Brachytherapy

Plaque radiotherapy is an important globe-preserving treatment.

It may be considered for:

• Larger tumors
• Diffuse tumors
• Tumors not suitable for excision
• Angle involvement
• Anterior chamber seeding
• Eyes in which preservation of useful vision is especially important

Radiation allows treatment of tissue beyond the visibly apparent tumor margin.

Enucleation

Enucleation is now reserved for advanced cases.

Indications may include:

• Extensive diffuse melanoma
• Involvement of a large portion of the iris and angle
• Severe uncontrolled secondary glaucoma
• Painful blind eye
• Extensive tumor seeding
• Extraocular extension in selected circumstances

Visual status of the fellow eye should be considered before proceeding.

Management of Glaucoma

Glaucoma should initially be treated medically when possible.

Filtering surgery such as trabeculectomy is generally avoided in eyes with active or incompletely controlled melanoma, because creating a surgical fistula could theoretically facilitate extraocular tumor spread.

When pressure cannot be controlled medically, options may include cyclodestructive procedures or other carefully selected interventions coordinated with an ocular oncologist.

Postoperative Treatment

After local excision or radiotherapy, topical medications may be used to control:

• Inflammation
• Pain
• Posterior synechiae

Cycloplegics and corticosteroid-containing regimens may be prescribed depending on the procedure and postoperative findings.

Follow-Up

Patients require long-term ocular surveillance.

Follow-up commonly includes:

• Slit-lamp examination
• Gonioscopy
• IOP measurement
• Anterior segment photography
• UBM
• Transillumination when appropriate

After treatment, follow-up is often performed approximately every 6 months, although intervals depend on tumor risk and stability.

Patient Monitoring

Monitoring focuses on:

• Tumor regression
• Recurrence
• New seeding
• Progressive angle involvement
• Secondary glaucoma
• Cataract
• Radiation complications

Systemic metastatic surveillance should continue long term.

Patient Education

Patients should understand that iris melanoma is malignant but generally has a better metastatic prognosis than choroidal melanoma.

They should be educated regarding the importance of:

• Long-term eye follow-up
• Lifelong systemic surveillance
• Reporting new eye pain or visual loss
• Monitoring previously suspicious iris lesions

Avoiding excessive ultraviolet exposure is reasonable.

Prognosis

The metastatic risk of iris melanoma is lower than that of choroidal or ciliary body melanoma.

Reported long-term metastatic rates are relatively low, but risk is not zero.

Features associated with a worse prognosis include:

• Older age
• Secondary glaucoma
• Angle involvement
• Extraocular extension
• More diffuse disease
• Higher-risk cytogenetic features

Early, localized lesions generally have a favorable ocular and systemic prognosis when appropriately treated.

Complications

Potential complications include:

• Secondary glaucoma
• Cataract
• Recurrent tumor
• Tumor seeding
• Angle invasion
• Radiation-related keratopathy
• Neovascular glaucoma
• Need for eventual enucleation
• Metastatic disease

After plaque radiotherapy, cataract is a particularly common late complication.

The key clinical warning is: an iris lesion with documented growth, intrinsic vessels, tumor seeding, angle involvement, or secondary glaucoma should be considered suspicious for iris melanoma until proven otherwise.